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Abstract 
Cancer is a complex group of heterogeneous diseases. Intensive research 
spanning almost 50 years has greatly broadened our understanding of how cancer 
forms and disseminates around the human body. Despite this, many open 
questions remain. In this time, there has been a rise in the use of alternative 
cancer models. One such cancer model is Drosophila melanogaster. 
 In this thesis I utilize Drosophila to: demonstrate a role of Drosophila 
p120ctn in the stress response and negative regulation of immune signalling; 
uncover novel mediators of Apc driven intestinal hyperplasia in the adult 
Drosophila midgut; and describe the role of the innate immune response in 
control of tumour burden in tumour bearing larvae.  
p120ctn is the founding member of the p120ctn family of proteins and is 
essential for adherens junction formation and stability in mammalian epithelia. 
It is required for vertebrate development and is deregulated in many epithelial 
cancers.  In Drosophila, a single p120ctn family member (dp120ctn) is not 
required for the formation of adherens junctions, development or homeostasis. I 
demonstrate that dp120ctn null adult flies are sensitive to specific stressors and 
possess a differential transcriptional profile reminiscent of infected flies. 
Additionally, combination of loss of dp120ctn with null mutations in polarity 
tumour suppressors resulted in increased tumour burden. Suggesting that 
dp120ctn may have conserved tumour suppressor activity. 
Adenomatous polyposis coli (Apc) is frequently mutated in human 
colorectal cancer. Apc loss in the mouse intestine leads to rapid tumourigenesis. 
Here, we have uncovered novel regulators of the Apc phenotype in the adult 
Drosophila midgut and describe a paracrine signalling cross-talk required for Apc 
driven hyperplasia. 
The systemic response to a growing tumour is poorly understood and cancer 
associated inflammation has paradoxical effects on tumour progression. Using 
Drosophila larval models of cancer we characterized the relationship between a 
growing tumour and the innate immune system. We demonstrate that larvae 
mount an immune response that requires activation of Toll signalling in the fat 
body and expression of Egr/TNF in the haemocytes to orchestrate tumour cell 
death and restrict tumour burden. 
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1 Introduction 
1.1 Cancer 
Cancer is a complex family of diseases, which can affect nearly every organ and 
system in the human body.  For a tumour to establish itself it must integrate 
several “hallmarks” of cancer (Hanahan and Weinberg, 2011). These include the 
ability to sustain proliferative signalling while at the same time becoming 
insensitive to apoptotic signals (Hanahan and Weinberg, 2011). This occurs when 
cells acquire activating mutations in oncogenes and deactivating mutations in 
tumour suppressor genes. Tumour progression is a complex and multistep 
process that is affected by interactions with the surrounding normal tissue and 
the immune system (Hanahan and Weinberg, 2011).  Once a primary tumour has 
exhausted its site of origin, tumour cells undergo further changes in order to 
invade and metastasize to a new location within the body (Hanahan and 
Weinberg, 2011). It is these latter phases of cancer progression that are the 
most lethal. During this process tumour cells engage in local invasion where they 
drive remodelling of the extracellular matrix (Hanahan and Weinberg, 2011). 
Invasive cells will enter a local blood or lymphatic vessel in order to reach other 
sites in the body. The cells will exit the vessel and form “micro-metastases” and 
eventually secondary tumours (Hanahan and Weinberg, 2011). Despite intensive 
studies in cell culture and in mouse models, many open questions remain. More 
recently, non-mammalian models like zebrafish and Drosophila melanogaster are 
been utilized to investigate aspects of tumourigenesis and tumour progression 
(White et al., 2013, Gonzalez, 2013).  
 
1.2 Drosophila as a model organism  
Drosophila melanogaster, also known as the fruit or vinegar fly, has been 
utilized as a model organism for over 100 years and has contributed greatly to 
the understanding of genetics and development (Schneider, 2000). Currently, 
Drosophila is one of the most characterized and widely used animal models. 
Drosophila research is providing insights into our understanding of ageing, 
neurodegenerative diseases, immunity, diabetes, addiction and cancer (Adams 
et al., 2000, Chan and Bonini, 2000, Vidal and Cagan, 2006, Stefanatos and 
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Vidal, 2011, Valanne et al., 2011).   A key to its popularity is the array of 
available tools for genetic manipulation. Temporal and spatial control of gene 
expression through the use of the yeast derived GAL4/UAS system, as well as the 
creation of genetically distinct mosaic clones allow in detail analysis of 
complicated and dynamic events (Brand and Perrimon, 1993, Theodosiou and Xu, 
1998, Lee and Luo, 2001). There is remarkable conservation of signalling 
pathways between flies and humans despite the evolutionary distance. 
Moreover, the Drosophila genome is significantly less redundant than the human 
genome making the genetic dissection of pathways simpler (Adams et al., 2000). 
 
1.2.1 The Drosophila Life Cycle  
The Drosophila melanogaster life cycle consists of an embryonic stage, followed 
by a larval stage, a pupa stage (metamorphosis) and finally the adult stage (Fig 
1.1). This life cycle takes approximately 10 days at 25°C. Adult Drosophila live 
around 70 days at 25°C and in that time can produce hundreds of offspring. 
Adult female flies become sexually mature within 8-12 hrs and each female can 
lay around 300 eggs. The embryos hatch 16 hrs after deposition and the hatched 
larvae proceed to eat for the next 5 days and undergo two molting stages. The 
mature third instar larvae wander out of the food and look for a dry place to 
pupate. After pupariation during metamorphosis, some larval tissues are 
remodeled and others removed completely as the adult fly develops. Many of 
the structures that will make up the adult fly are derived from epithelial mitotic 
sacs known as the imaginal discs (Lewis I. Held, 2002, Weigmann et al., 2003). 
  
	   22 
Figure 1.1 The life cycle of Drosophila melanogaster. 
Picture depicting the life cycle of Drosophila melanogaster. From egg to adult 
fly, development takes 10 days at 25°C. Taken from (Weigmann et al., 2003). 
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1.2.2 Drosophila Genetics and Husbandry 
Drosophila melanogaster are one of the cheapest laboratory animals to 
culture, as they require very little space and starting equipment. They can be 
kept in either vials or bottles that contain an agar set yeast-sugar medium (see 
Chapter 2) that they eat and lay eggs on to. They are cold and oxygen sensitive 
and can be cultured at temperatures varying from 18-29°C using incubators or 
dedicated “Fly rooms”.  
The Drosophila genome contains around 15,000 genes arranged on just 4 
chromosomes. They are the X (1st), 2nd, 3rd and 4th chromosomes that are divided 
by the centromeres into left and right arms. Drosophila were historically used to 
uncover the nature of genes this led to the isolation of many mutants from the 
natural population.  Mutagenic agents such as X-ray irradiation, Ethyl 
methanesulphonate and transposable P-elements have been used over the years 
to isolate new mutants and therefore discover new genes required for 
development of Drosophila. The ability to easily generate mutants allowed 
researchers to do large screens looking for aberrations in patterning and 
morphology in the early embryo as well as in the adult stage of development.  
This painstaking work is responsible for much of our understanding of Drosophila 
development.  In the early 1990’s two more tools were added to the Drosophila 
tool kit, the GAL4/UAS and the FLP-FRT systems are in later sections.  
Experimental crosses are normally performed at 25°C using virgin females 
and males from stock cultures that carry mutations or transgenes that we want 
to combine. As it would be highly impractical to genotype all the progeny every 
time you perform a cross, we use phenotypic markers, such as curly wings or eye 
colour and shape, that are associated to the gene or transgene we are interested 
in so that we the progeny of interest can be identified by the presence or 
absence of these phenotypic markers. These stock cultures are a very important 
part of any Drosophila laboratory and the flies need to be transferred to new 
food every 2-3 weeks. However, if any disasters do occur there are major stock 
centers that hold and maintain many thousands of essential Drosophila stocks 
from which stocks can be ordered. Another very important tool in Drosophila 
genetics are the “Balancer Chromosomes”. Balancer chromosomes are 
chromosomes that carry multiple inversions and rearrangements and therefore 
cannot recombine with wild type chromosomes. They normally also carry one or 
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multiple dominant markers and recessive lethal markers making them 
indispensable for maintaining mutants stocks and for following complicated 
genetic combinations.  
 
1.2.3 Targeted gene expression in Drosophila using the Gal4/UAS system 
Gal4 is a yeast transcriptional activator that binds to an upstream activating 
sequence (UAS), which contains Gal4 binding sites. Using this system, it is 
possible to express any cloned gene that is flanked by UAS (Brand and Perrimon, 
1993). It is a binary system, where the Gal4 and the UAS target gene are 
expressed by different transgenic flies that must be combined through mating to 
drive expression (Brand and Perrimon, 1993) (Fig 1.2). 
 
1.2.3.1 Extensions of the Gal4/UAS system: Gal80. 
The Gal80 repressor binds to Gal4 transcriptional activation domain and blocks 
its activity (Ma and Ptashne, 1987). Thus, expression of Gal80 can be used to 
prevent Gal4-driven expression. Temperature sensitive variants of Gal80 protein 
(Gal80ts) allow temporal control over Gal4/UAS expression through changes in 
temperature (Matsumoto et al., 1978, McGuire et al., 2003). At the permissive 
temperature Gal80 becomes inactive and allows Gal4 to activate the 
transcription.  
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Figure 1.2 The Gal4/UAS system for targeted gene expression. 
Schematic describing the Gal4/UAS system for targeted gene expression. The 
system consists of two components: the yeast transcriptional activator Gal4 
(green hexagon) and the Upstream Activating Sequence (UAS) (red circles) 
element containing eukaryotic elements which are bound by Gal4 to activate 
gene expression. Placing Gal4 downstream of a tissue specific enhancer element 
(dark green rectangle) results in tissue specific expression of Gal4. Placing a UAS 
upstream of any gene will result in expression of this gene in tissues also 
expressing Gal4.  
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1.2.4 The FLP/FRT system 
In Drosophila, we can create genetically distinct clones of cells using the yeast 
derived site-specific recombinase FLP coupled with FLP recombination targets 
(FRT) (Dang and Perrimon, 1992, Theodosiou and Xu, 1998) (Fig 1.3). This system 
works having identical FRT recombination sites for the FLP to act on. There are 
FRT sites on each on the major arms of 3 of the 4 chromosomes. The 
introduction of this system allowed the analysis of mutations in clones of cell 
that could be engineered in a specific tissue, by controlling the expression of the 
FLP by placing downstream of a tissue specific enhancer, and at a specific 
developmental time point, by using a temporally regulated enhancer, allowing a 
much more sophisticated functional dissection of essential genes. This simple 
method can also be used to overexpress UAS transgenes in a subset of cells in an 
otherwise wild type animal.  This type of experiment can be very useful when 
trying to look for genes that may cooperate or are required for a mutant 
phenotype, enhancers or suppressors. 
 
1.2.4.1 Mosaic analysis with a repressible marker (MARCM) 
The MARCM system is an extension of the FLP/FRT system with which we can 
uniquely mark homozygous mutant clones (Fig 1.4, see legend for more details) 
(Lee and Luo, 2001) and utilizes the Gal4 repressor Gal80 (Fig 1.4, see legend for 
more details). This is important as it means that you can easily score clone size 
and number by expressing GFP or RFP to mark the cells your interested in. This 
system has successfully been used to screen for genes with a role in oncogenic 
cooperation and interactions with the tumour microenvironment. In this thesis, 
we have utilized a temperature sensitive form of the Gal4 repressor Gal80 to 
understand the contribution of different signalling pathways to pre-established 
Apc1 dependent hyperproliferation in the Drosophila midgut. 
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Figure 1.3 The FLP/FRT system 
Schematic diagram depicting how use of the FLP/FRT system allows creation of 
in this case scribble (scrib) mutant cells. In this diagram you can see both 3rd 
chromosomes (Green and Purple line) of Drosophila carrying one copy of a 
mutant allele for the scribble gene (grey box) and FRT sites at identical positions 
(black arrowhead). After DNA replication, the FLP recombinase mediates 
recombination of the region of the chromosome distal to the FRT site. In this 
example, mitosis leads to the formation of a scribble mutant cell and a wild type 
cell in a fly that will be heterozygous for scribble. This is important for probing 
the roles of genes that have essential functions but are haplosufficient.  
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Figure 1.4 Mosaic analysis with a repressible marker system (MARCM) 
Crossing scheme and schematic diagram depicting how the addition of the Gal4 
repressor Gal80 (see Fig 1.2) to the FLP/FRT system (see Fig 1.3) allows creation 
of scribble (scrib1) mutant cells which will also be marked with GFP (UAS-GFPNLS) 
and over express oncogenic Ras (UAS-RasV12) specifically in the eye (eyeless (eye 
specific gene) FLP. In this diagram you can see both 3rd chromosomes (Green and 
Purple line) of the F1 carrying either a copy of a mutant allele for the scribble 
gene (grey box) or Gal80 under control of the tubulin enhancer (magenta box) 
distal to FRT sites (black arrowhead). After DNA replication, the FLP 
recombinase mediates recombination of the region of the chromosome distal to 
the FRT site. In this example, mitosis leads to the formation of a GFP positive 
scribble mutant cell expressing oncogenic Ras and a GFP negative type cell in 
the eye of flies that will be otherwise wild type. It is important to note that all 
the cells carry all the transgenes and mutations however only cells in which the 
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eyeless promoter is active will recombination occur and only in those cells 
where Gal80 is no longer present will GFP and oncogenic Ras be expressed.  
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1.2.5 The Drosophila Imaginal Discs 
In the Drosophila larvae, each imaginal disc is located in a specific location 
along the length of the animal (Lewis I. Held, 2002). As the larval stage 
progresses the imaginal discs proliferate and become locked in a developmental 
fate (Lewis I. Held, 2002). This is orchestrated by specific and discrete 
expression of several morphogens. By the late 3rd instar larval stage each 
imaginal disc is a highly folded monolayer of columnar pseudo-stratified 
epithelium with a layer of squamous epithelium known as the “peripodial 
membrane” (Lewis I. Held, 2002). During metamorphosis (pupa stage) stage the 
imaginal discs elongate and evert to form the adult structures that they are 
programmed to produce (Lewis I. Held, 2002).  
 
1.2.5.1 The Wing Imaginal Disc 
Each Drosophila larvae contains a pair wing imaginal discs that will form the 
adult wings and body wall during metamorphosis (Lewis I. Held, 2002). The wing 
disc is divided along the anterior/posterior and dorsal/ventral axes (Lewis I. 
Held, 2002). These boundaries are defined by expression of Decapentaplegic 
(Dpp) (A/P) and Vestigial (Vg) (D/V) (Lewis I. Held, 2002). As wing development 
and cell fate is highly controlled we are able to use these discreet patterns of 
expression together with the Gal4/UAS system to overexpress or down-regulate 
genes within specific compartments (Brand and Perrimon, 1993).  
 
1.2.6 The Adult Drosophila Intestine 
The adult Drosophila intestinal tract is a simple tube made up of a monolayer 
epithelium surrounded by a layer of visceral muscle and trachea (Cordero and 
Sansom, 2012). The trachea represent the respiratory system of Drosophila and 
are a network of tubular chitin that delivers oxygen around the fly (Campos-
Ortega, 1985. ). The Drosophila gut can be divided into 3 main regions, the 
foregut, midgut and hindgut (Buchon et al., 2013).  The midgut, which is the 
main site of digestion, is lined by a semipermeable peritrophic matrix that 
regulates the passage of material from the lumen to the enterocytes below 
(Buchon et al., 2013). The midgut is made up of large absorptive Enterocytes 
(ECs), small Enteroendocrine cells (ee), pluripotent intestinal stem cells (ISCs) 
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and transient Enteroblasts (EBs) (Ohlstein and Spradling, 2006, Micchelli and 
Perrimon, 2006). The midgut can also be subdivided into the anterior, middle 
and posterior midgut (Buchon et al., 2013). Most studies including the work in 
this thesis focus on the posterior midgut (Buchon et al., 2013).  
 
1.2.7 The Drosophila Immune system 
The Drosophila Immune system comprises of only an innate immune response 
that includes both systemic and local responses to bacterial and fungal infection 
(Charroux and Royet, 2010). Pathogenic infection induces a systemic response 
that is accompanied by striking changes in gene transcription. These 
transcriptional changes are regulated by the Toll and Immune deficiency (Imd) 
signalling pathways (De Gregorio et al., 2001, De Gregorio et al., 2002). 
Activation of these pathways is required for resistance to bacterial and fungal 
infection (Lemaitre et al., 1996, Rutschmann et al., 2002). 
 At the cellular level the Drosophila immune response is carried out by 
the haemocytes that phagocytize bacteria and the fat body that produces 
antimicrobial peptides (AMPs) and secretes them into the haemolymph (Lemaitre 
and Hoffmann, 2007). The Drosophila genome encodes for around 20 AMPs 
belonging to seven classes. Analysis of their promoter regions of has shown Toll, 
Imd or Toll and Imd transcriptional regulation of these genes (Boman et al., 
1972, Bangham et al., 2006, Lemaitre and Hoffmann, 2007). AMPs are small 
cationic peptides whose mechanism of action is still unknown but increasing the 
genetic dose of these peptides has been shown to promote resistance to 
infection (Tzou et al., 2002).  
 
1.2.7.1 The Toll pathway 
The Drosophila Toll pathway is an evolutionary conserved signalling pathway 
that is required for resistance to fungal and gram-positive bacterial infection 
(Valanne et al., 2011) (Fig 1.5). The pathway is activated when a cleaved 
Spätzle dimer binds to the Toll receptor (Lemaitre et al., 1996, Valanne et al., 
2011, Shia et al., 2009). Once activated, the Toll receptor binds to the Myd88 
adaptor that interacts with tube and pelle, leading to the phosphorylation and 
eventual degradation of cactus, a negative regulator of the pathway (Valanne et 
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al., 2011). Once cactus has been degraded, the Rel/NF-κB like transcription 
factors Dorsal and Dorsal related immunity factor (DIF) translocate to the 
nucleus where they activate transcription of many antimicrobial genes (Lemaitre 
and Hoffmann, 2007, Valanne et al., 2011).  In Drosophila, the specificity of Toll 
activation to gram-positive bacteria and fungi is achieved through recognition 
proteins that activate Spätzle processing enzyme (SPE) to cleave Spätzle (Michel 
et al., 2001). This ensures that Toll signalling is only activated during infection 
with gram-positive bacteria or fungi.  
 
1.2.7.2 The Imd pathway 
The Drosophila Imd pathway was named after the imd immune deficient mutants 
(Lemaitre et al., 1995) (Fig 1.5). Imd signalling is induced upon infection with 
gram-negative bacteria (Gottar et al., 2002). The membrane bound 
peptidoglycan recognition protein LC (PGRP-LC) is activated by binding of 
peptidoglycan (Gottar et al., 2002). Once activated PGRP-LC interacts with Imd 
at the cell surface. Imd is then bound by the FADD adaptor intracellularly 
(Lemaitre and Hoffmann, 2007). FADD recruits the Dredd caspase that will 
cleave phosphorylated Relish and allow nuclear translocation of the Rel domain 
to activate transcription of antimicrobial peptides like Diptericin and Attacin 
(Lemaitre and Hoffmann, 2007). This cascade also requires the IKK signalling 
complex composed of IKKβ/Kenny (Key) and IKKγ/ird5 that phosphorylates Relish 
(Lemaitre and Hoffmann, 2007). This is postulated to happen upon activation of 
IKK by the MAP3K TAK1 and the adaptor TAB2 and may be dependent on FADD or 
Drosophila Inhibitor of Apoptosis 2 (DIAP2) (Lemaitre and Hoffmann, 2007).  
Mutations in any of these canonical components of Imd signalling results in 
phenotypes that phenocopy that of the original imd mutants (Lemaitre et al., 
1995). Although Imd signalling is not fully understood, it is known that Imd 
signalling is carefully regulated (Lemaitre et al., 1997, Boutros et al., 2002). 
Many positive regulators and negative regulators have been identified and are 
thought to limit the response to infection (Kleino et al., 2008). This is in 
accordance with the expression patterns observed for Imd specific AMPs 
(Lemaitre et al., 1997). The Drosophila Imd signalling pathway closely resembles 
the mammalian TNFR signalling pathway as they share many components 
(Lemaitre and Hoffmann, 2007). 
	   33 
 
 
Figure 1.5 The Toll and IMD pathways 
The Toll signalling pathway (analogous to the mammalian Toll like Receptor 
signalling pathway) is activated when the ligand Spätzle binds the Toll receptor 
upon infection with gram +ve bacteria. This leads to the release of the NF-κB 
like transcription factors Dorsal and DIF to translocate to the nucleus and induce 
many Toll regulated antimicrobial genes. The Immune Deficiency (Imd) pathway 
(that shares many components with the mammalian TNFR signalling pathway) is 
activated upon infection with gram –ve bacteria. Pattern recognition receptors 
detect the presence of bacterial peptidoglycan that leads to cleavage of the NF-
κB like transcription factor relish allowing it to translocate to the nucleus and 
induce many Imd regulated antimicrobial genes (PGRP-Pattern recognition 
receptor protein). See text for more details.  
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1.2.7.3 The Drosophila haemolymph 
Drosophila haemolymph is analogous to mammalian blood (Parisi and Vidal, 
2011). However unlike in mammals there is no vasculature in Drosophila. 
Instead, the fly possesses an open circulatory system where the organs are 
bathed in the haemolymph that contains haemocytes (blood cells), nutrients and 
factors secreted by the peripheral tissues and is pumped around by the 
Drosophila heart or Dorsal Vessel (DV) (Bate and Martinez-Arias, 1993, Meister 
and Lagueux, 2003). The haemocytes originate from the procephalic mesoderm 
and are important for embryonic development, metamorphosis and innate 
immunity (Meister and Lagueux, 2003, Wood and Jacinto, 2007). They compose 
of three classes, the plasmatocytes, the lamellocytes and the crystal cells. The 
plasmatocytes, analogous to mammalian macrophages or monocytes, are 
responsible for phagocytosis of apoptotic cells and microorganisms and act as 
immune surveillance cells (Meister and Lagueux, 2003, Wood and Jacinto, 2007). 
The lamellocytes, which have a flat and spread morphology, are important for a 
process called encapsulation that is induced when parasitoid wasps lay their eggs 
in the larvae (Lemaitre and Hoffmann, 2007). Finally the crystal cells are 
important for melanization at sites of injury.   
 
1.2.7.4 The Drosophila Fat body 
The Drosophila fat body is a storage and secretory tissue. It is analogous to the 
mammalian liver and adipose tissue (Boman et al., 1972). It is part of the 
systemic immune response and is the site of antimicrobial peptide (AMPs) 
production (Boman et al., 1972). 
 
1.3 Drosophila as a model in Cancer research 
Drosophila models of cancer have been successfully utilized to model diverse 
aspects of tumour progression (Vidal and Cagan, 2006, Stefanatos and Vidal, 
2011, Rudrapatna et al., 2012, Gonzalez, 2013). The use of Drosophila to model 
cancer allows in vivo analysis of genetically defined tumours in a highly 
tractable and well established invertebrate model (Vidal and Cagan, 2006, 
Stefanatos and Vidal, 2011, Rudrapatna et al., 2012, Gonzalez, 2013). 
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Although not widely appreciated, early fruit fly research reported the 
development of hereditary tumours (Stark, 1918, Harshbarger and Taylor, 1968, 
Gateff, 1978) and the first tumour suppressor was isolated in Drosophila (Stern 
and Bridges, 1926). This discovery provided early evidence for the existence of 
tumour suppressor genes and predates the discovery of mammalian tumour 
suppressors by many decades. Recent studies in ageing flies demonstrated the 
presence of tumours in a significant proportion of adult flies (Salomon and 
Jackson, 2008). Moreover, many components of signalling pathways like the Wnt, 
TGF-β and Notch pathways that are often miss-regulated in cancer were first 
discovered in Drosophila (Greenwald, 1998, Raftery and Sutherland, 1999, 
Cadigan and Peifer, 2009).  Thus, Drosophila is a powerful model for cancer 
research. 
 
1.3.1 The scribble group of polarity tumour suppressors  
The scribble (scrib) group of polarity regulators includes scrib, discs large (dlg) 
and lethal giant larvae (lgl) (Bridges and Brehme, 1944, Mechler et al., 1985, 
Bilder et al., 2000, Bilder and Perrimon, 2000). These proteins define apico-
basal polarity in Drosophila epithelia and are well conserved (Bilder and 
Perrimon, 2000, Bilder et al., 2000, Dow et al., 2003, Lohia et al., 2012).  Loss 
of function mutations in any of these genes results in loss of apico-basal polarity 
and neoplastic overgrowth of the brain and imaginal discs of developing larvae 
(Bilder and Perrimon, 2000, Bilder et al., 2000, Humbert et al., 2008). 
Homozygous mutant larvae become arrested at the larval stage and die as giant 
larvae (Woods and Bryant, 1991, Bilder et al., 2000).  In order to build more 
relevant models of cancer, Mosaic Analysis with a Repressible Cell Marker system 
(MARCM) which allows the establishment of homozygous mutant cell clones 
within a heterozygous and thus normal tissue, was used to create clones of cells 
mutant for scrib group tumour suppressors specifically in the eye imaginal disc 
(Brumby and Richardson, 2003). Alone these mutant clones rapidly disappear 
from the epithelium through JNK dependent apoptosis (Brumby and Richardson, 
2003). However, if the RasV12 oncogene was overexpressed together with loss of 
scrib within the clones, the clones proliferated and formed invasive neoplasia 
with metastasis that killed the larvae (eyRasV12; scrib1) (Brumby and Richardson, 
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2003, Pagliarini and Xu, 2003). These studies together demonstrate the power 
of Drosophila as a tool to uncover novel regulators of invasion and metastasis.   
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2 Materials and Methods  
2.1 Flies 
2.1.1 Fly husbandry 
Flies were crossed and maintained on standard media in incubators with 
temperatures varying from 18°C to 29°C with a controlled 12hr-light: 12hr-dark 
cycle.  Fly were anaesthetised using CO2, pushed using paintbrushes and visualised 
using a Leica dissection microscope. All experiments were carried out at 25°C 
unless otherwise stated. Stocks were maintained at 18°C. 
Standard Media: 10g Agar, 15g Sucrose, 30g Glucose, 15g Maize meal, 10g wheat 
germ, 30g treacle and 10g Soya flour per litre of distilled water.  
10ml of Nipagin/Methylparaben (Deutscher scientific, Anti-fungal) and 5ml of 
Propionic acid (Fisher, anti bacterial agent) per litre distilled water were also 
added to the food mix. 
Food was prepared by Beatson Central services according to this recipe. 
 
2.1.2 Fly stocks 
Fly stocks were kindly provided to us by our colleagues or obtained from the 
Bloomington, Drosophila Genome Resource (DGRC) and Vienna Drosophila RNAi 
Centre (VDRC) stock collections.  A full list of stocks and their sources can be 
found in Table 2.1. 
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Strain/Genotype/Class Description Source/Reference 
Control strains 
Canton S Wild type strain of 
Drosophila 
Vidal lab stocks 
w1118 allele of white mutant - 
flies have white eyes. 
Vidal lab stocks 
Strain/Genotype/Class Description Source/Reference 
Mutants 
Apc1Q8 loss of function allele, 
point mutation isolated 
from screen 
(Ahmed et al., 1998) 
Apc1x1 loss of function allele, 
point mutation isolated 
from screen 
(Ahmed et al., 1998) 
Apc1S76 loss of function allele, 
point mutation isolated 
from screen 
(Ahmed et al., 1998) 
scrib1 loss of function allele of 
scribble created by EMS 
mutagenesis 
(Bilder and Perrimon, 
2000) 
dlg40.2 loss of function allele of 
discs large for PDZ 
created by p-element 
excision 
(Mendoza-Topaz et al., 
2008) 
l(2)gl4 loss of function allele of 
lethal giant larvae, 
natural mutation isolated 
from population 
(Bridges and Brehme, 
1944) 
egr1 loss of function allele of 
eiger created by p-
element excision 
(Igaki et al., 2002) 
egr3 loss of function allele of 
eiger created by p-
element excision 
(Igaki et al., 2002) 
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relE20 loss of function allele of 
relish created by p-
element excision 
(Hedengren et al., 1999) 
p120308 p120 catenin null allele 
created by p-element 
excision 
(Myster et al., 2003) 
Strain/Genotype/Class Description Source/Reference 
Gal4 drivers 
esg-Gal4,UAS-GFP/+; 
tubGal80ts/+ 
temperature regulated 
GAL80 repressor 
combined with Gal4 
driver for escargot driving 
GFP. Drives expression in 
ISCs and EBs 
Hayashi, Shigeo (RIKEN 
Center for 
Developmental Biology) 
MyoIA-Gal4/+; UAS-
GFP, tub-Gal80ts/+ 
temperature regulated 
GAL80 repressor 
combined with GAL4 
driver for MyoIA driving 
GFP. Drives expression in 
ECs 
Edgar, Bruce (DKFZ, 
Heidelberg) 
spitz-Gal4NP0261 Gal4 driver insertion in 
spitz. Recapitulates spitz 
expression pattern 
DGRC - 112114 
CG-Gal4 Gal4 driver for cg25c 
(collagen)- drives 
expression in the 
haemocytes, fat body and 
lymph glands 
Bloomington 7011 (Asha 
et al., 2003) 
Hml-Gal4 Gal4 driver for 
hemolectin drives 
expression in the 
haemocytes 
Bloomington 30139 
(Goto et al., 2001) 
He-Gal4 Gal4 driver for hemese 
drives expression in the 
haemocytes 
Bloomington 8699 
(Kurucz et al., 2003) 
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ppl-Gal4 Gal4 driver for pumpless 
drives expression in the 
fat body 
Leopold, Pierre (iBV, 
Nice) (Zinke et al., 
1999) 
Strain/Genotype/Class Description Source/Reference 
UAS-Transgenes 
UAS-DERDN (EGFR) UAS Transgene expressing 
a dominant negative form 
of EGFR 
Freeman, Matthew (MRC 
LMB, Cambridge) 
UAS-GFP UAS Transgene expressing 
GFP 
Bloomington 6874 
UAS-wg UAS Transgene expressing 
wingless 
Bloomington 5918 
UAS-egrvenus UAS Transgene expressing 
eiger fused with a Venus 
fluorescent tag 
Davis,G (UCSF) 
UAS-Toll UAS Transgene expressing 
Toll fused with a Venus 
fluorescent tag 
Bloomington 30899 
Strain/Genotype/Class Description Source/Reference 
RNA interference lines (RNAi) 
UAS-STAT-IR UAS RNA interference 
transgene for STAT 
VDRC - 43866 
UAS-domeless-IR UAS RNA interference 
transgene for domeless 
VDRC - 2612 
UAS-Max-IR UAS RNA interference 
transgene for Max 
Gallant, Peter (UZH, 
Zurich) 5(Steiger et al., 
2008) 
UAS-Myc-IR UAS RNA interference 
transgene for Myc 
VDRC - 2947 
UAS-Apc1-IR (II) UAS RNA interference 
transgene for Apc1 
VDRC - 51468 
UAS-Apc1-IR (III) UAS RNA interference 
transgene for Apc1 
VDRC - 51469 
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UAS-spitz-IR UAS RNA interference 
transgene for spitz 
VDRC - 3920 
UAS-eiger-IR UAS RNA interference 
transgene for eiger 
VDRC - 108814 
UAS-spätzle-IR UAS RNA interference 
transgene for spätzle 
VDRC - 105017 
UAS-Myd88-IR UAS RNA interference 
transgene for Myd88 
VDRC - 19691 
UAS-dlg-IR UAS RNA interference 
transgene for discs large 
VDRC - 41134 
UAS-Pvr-IR UAS RNA interference 
transgene for Pvr (PDGF 
and VEGF receptor 
homolog) 
VDRC - 105353 
Strain/Genotype/Class Description Source/Reference 
MARCM lines 
y,w,hsFlp/+; UAS-CD8-
gfp, tub-gal4/+; 
FRT82B, tub-
gal80/tm6b 
MARCM line Bilder, David (UC, 
Berkeley) 
FRT82B UAS-LacZ FRT82B recombination 
site carrying UAS 
Transgene expressing 
bacterial LacZ 
Cagan Lab stocks 
 
Table 2.1: Fly stocks used in this study 
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2.1.3 Backcrossing 
In order to isogenize mutant flies into control backgrounds mutants were 
backcrossed to wild type strains for 10 generations.  
 
2.1.4 RNA interference 
RNA interference (RNAi) was first discovered in Caenorhabditis elegans 
(C.elegans). In Drosophila, it is now routinely used for gene knockdown. It allows 
gene silencing through the use of specific RNA sequences that target mRNA for 
degradation. 
 
2.1.5 MARCM analysis 
In order to measure ISC proliferation in the posterior midgut we generated 
recombinant clones using the MARCM technique that allows the analysis of 
homozygous mutant populations of cells within a wild type tissue (Lee and Luo, 
2001).  Crosses were maintained at 22°C.  3-5 day old adult females of the 
desired genotypes were selected and subjected to three 30 min heat shocks at 
37°C in one day with a break of 2 hours after each heat shock to induce clones.  
Flies were then incubated at 25°C and their guts dissected for analysis two 
weeks after clone induction.  
 
2.1.6 Regression experiments 
In order to assay the effect of knockdown of specific genes on hyper 
proliferation in the midgut we employed a temperature sensitive Gal4 repressor 
(Gal80ts) in combination with either an ISC/EB Gal4 driver (esg-Gal4ts) or the 
MARCM system. 
esg-Gal4ts: Adults were kept at 22ºC for 5 days. Midguts were dissected at this 
time point or flies were transferred to 29ºC for a further 7 days to allow 
expression of RNAi transgenes and then analyzed.  
MARCM clones: Clones were induced and flies were incubated at 22ºC for 14 
days. After the first 14 days all flies were switched to 29ºC and midguts were 
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dissected after 1 day (15 day-old clones; 15d), 7 days (21 day-old clones; 21d) 
and 14 days (28 day-old clones; 28d) of incubation at 29ºC.  
 
2.1.7 Lifespan analysis 
Flies were collected using CO2 anaesthesia within 12 hours of eclosion and 
allowed to mate at 25°C for 2 days at a density of 20 flies per vial.  Flies were 
transferred to new vials and placed at either 25°C or 29°C.  Every 2-3 days the 
flies were transferred to fresh food and the number of dead flies was counted. 
 
2.1.8 Fly collection for stress assays 
For all stress tests flies were collected and aged using the same method. Flies 
were collected using CO2 anaesthesia within 12 hours of eclosion and allowed to 
mate at 25°C for 2 days at a density of 20 flies per vial. They were separated 
into males and females and allowed to age at 25°C for a further 4 days. 
 
2.1.9 Heat shock stress assay 
Flies were transferred into empty vials and placed in a water bath set at 37°C. 
Dead flies were counted at 15min intervals. The experiment was terminated 
when all flies were dead. 
 
2.1.10 Starvation assay 
Flies were transferred into vials containing 5ml of 1% agar and placed in a 25°C 
incubator. Dead flies were counted at 12hr intervals. The experiment was 
terminated when all flies were dead. 
 
2.1.11 Osmotic stress assay 
Flies were transferred into vials containing 5ml of 1% agar and then placed in a 
25°C incubator for overnight starvation. Flies were then transferred to vials with 
5ml of standard medium containing 6% NaCl. Media was changed daily and dead 
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flies were counted at 12hr intervals. The experiment was terminated when all 
flies were dead. 
 
2.1.12 H202 feeding assay 
Flies were transferred into vials containing 5ml of 1% agar and then placed in a 
25°C incubator for overnight starvation.  Flies were then transferred to vials 
with 5ml of 1% agar containing 5% Sucrose and 1% H202. Media was changed daily 
and dead flies were counted at 12hr intervals. The experiment was terminated 
when all flies were dead. 
 
2.1.13 Paraquat feeding assay 
Flies were transferred put into vials containing 5ml of 1% agar and then placed in 
a 25°C incubator for overnight starvation. Flies were then transferred to vials 
containing filter paper (Whatman) soaked in 300µl of 5% Sucrose plus 20µM 
Paraquat and maintained at 25°C. Dead flies were counted at 12hr intervals. The 
experiment was terminated when all flies were dead. 
 
2.2 Immunofluorescence of Drosophila tissues 
2.2.1 Fixation and antibody staining 
Adult and larval tissues were dissected in PBS and fixed 30–45 min in 4% para-
formaldehyde (Polysciences, Inc.) using two nº 5 forceps (Dumont) and Leica 
dissection microscope. After fixation, three 15 min washes in PBS + 0.3% TritonX-
100 (PBST) were performed. Samples were incubated overnight at 4°C in primary 
antibodies and DAPI (1:1000) in PBST+3% Bovine Serum Albumin (BSA) (Sigma). 
Samples were then washed as before and incubated with secondary antibodies 
(Invitrogen – Life technologies) in PBST for 1-2hrs at room temperature. Samples 
were mounted on polylysine glass slides (Thermo Scientific) with 13mm x 
0.12mm spacers (Electron Microscopy Sciences) and Vectashield mounting media 
(Vector Laboratories, Inc.). For dissection of wild types wing discs spacers were 
not used to keep the tissue flat. For Wg staining tissues were fixed in PEM-FA 
(0.1 M PIPES, 2 mM EGTA, 1.0 mM MgSO4, 3.7% formaldehyde, pH 7.0) for 20 min 
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and then washed with PBST (Lin et al., 2008). From here the standard staining 
protocol described above was used. 
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2.2.2 Antibodies 
Antibody Description Dilution Source/Ref 
Primary Antibodies 
anti-GFP Chicken, polyclonal 
against full length 
eGFP 
1:4000 abcam - 
ab13970 
anti-Delta Mouse, monoclonal 
against extracellular 
domain of Delta 
1:30 Developmental 
Studies 
Hybridoma Bank 
(DSHB)– C594.9B 
anti-Pros Mouse, monoclonal 
against Prospero 
protein 
1:20 DHSB 
anti-Arm Mouse, monoclonal 
against N-terminal 
domain of Armadillo 
1:3 DHSB- MR1A 
anti-pH3S10 Rabbit, polyclonal 
against Ser10 
phosphorylated 
Histone H3 
1:100 Cell signalling - 
9701 
anti-pH3S28 Rabbit, polyclonal 
against Ser28 
phosphorylated 
Histone H3 
1:100 Cell signalling - 
9713 
anti-Myc Guinea pig, 
polyclonal against 
Drosophila Myc 
1:100 
pre-
absorbed 
Morata, G (SIC-
UAM, Madrid) 
anti-βgal Rabbit, polyclonal 
against β-gal 
1:1000 Cappel 
Antibodies 
anti-Pdm1 Rabbit, polyclonal 
against Pdm-1 
(nubbin) 
1:500 Chia, W (King's 
College, 
London) 
anti-CC3 Rabbit, polyclonal 
against large cleaved 
caspase 3 fragment 
at Asp175 
1:200 Cell signalling – 
9661L(lot-36) 
anti-MMP1 Mouse, monoclonal 
against catalytic 
domain of MMP1 
1:10 DHSB – 3B8D12 
anti-p1 Mouse, monoclonal 
against nimrod 
(marks all 
plasmatocytes) 
1:5 Ando, I (Kurucz 
et al., 2007) 
	   47 
Antibody Description Dilution Source/Ref 
Secondary Antibodies 
anti-chi-IgG-
488 
Goat, polyclonal 
against chicken IgG, 
conjugated to Alexa 
Fluor 488 
1:200 Invitrogen - 
A11039 
anti-ms-IgG-
488 
Goat, polyclonal 
against mouse IgG, 
conjugated to Alexa 
Fluor 488 
1:200 Invitrogen - 
A11029 
anti-ms-IgG-
594 
Goat, polyclonal 
against mouse IgG, 
conjugated to Alexa 
Fluor 594 
1:100 Invitrogen - 
A11032 
anti-rb-IgG-
594 
Goat, polyclonal 
against rabbit IgG, 
conjugated to Alexa 
Fluor 594 
1:100 Invitrogen - 
A11037 
anti-gp-IgG-
594 
Goat, polyclonal 
against guinea pig 
IgG, conjugated to 
Alexa Fluor 594 
1:100 Invitrogen - 
A11076 
anti-rb-IgG-
Cy5 
Donkey, polyclonal 
against rabbit IgG, 
conjugated to Alexa 
Fluor 488 
1:50 Jackson 
Laboratories - 
711-176-152 
Phalloidin - 
647 
High affinity F-Actin 
probe, conjugated to 
Alexa Fluor 647 
1:40 Invitrogen - 
A22287 
anti-ms-HRP Rabbit, polyclonal 
against mouse IgG 
conjugated to HRP 
 
1:5000 Abcam - 97046 
Table 2.2: Primary and Secondary Antibodies used in this study. 
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2.2.3 Microscopy and Image processing 
2.2.3.1 Light and Fluorescent light microscopy 
All images of 3rd instar larvae were taken using a Leica M205 FA 
stereomicroscope.  
 
2.2.3.2 Confocal microscopy 
All confocal imaging was performed in the Beatson Advanced Imaging Resource 
(BAIR) using the Zeiss 710 LSM confocal microscope. Raw data was stored as LSM 
files.  Confocal stacks were processed using Image J (National Institutes of 
Health) and Adobe Photoshop.  
 
2.3 Quantifications  
2.3.1.1 Quantification of pH3+ve cells 
In order to quantify the level of proliferation in the posterior midgut of different 
genotype, the total number of the cells in the posterior midgut was counted. For 
each genotype at least 10 posterior midguts were analysed.   
 
2.3.1.2 Quantification of number of cells per clone  
In order to quantify the level of proliferation within clones in the posterior 
midgut of different genotypes, the total number of cells per clone in the 
posterior midguts was counted using DAPI positivity.  For each genotype at least 
30 clones were counted.   
 
2.3.1.3 Quantification of larval Haemocyte number 
In order to quantify the number of circulating haemocytes in different 
genotypes, larvae were washed three times in PBS to remove any food debris. 5 
larvae per genotype were then opened and turned inside out using two nº 5 
forceps (Dumont) in 200µl of PBS. The sample was gently pipetted to ensure 
equal distribution and avoid clustering. 10µl were loaded into each end of a 
Bright Line haemocytometer. The total number of haemocytes in 10 squares was 
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counted and was used to calculate the average total number of haemocytes. 
The average total number of haemocytes was calculated per larva. These 
experiments were performed at least in triplicate for each genotype i.e. a 
minimum of 15 larvae per genotype.  
 
2.3.1.4 Quantification of total DAPI positive volume  
In order to compare the sizes of tumours from different genotypes, tumour 
Volume was quantified as the total volume of DAPI from individual series of 
confocal images. This was carried out using Volocity 3D image analysis software. 
For each tumour 40-50 images were taken at around 2.55µm per image step 
depending on the size of the tumour. At least 10 tumours were analysed for each 
genotype. 
 
2.3.1.5 Quantification of percentage Cleaved Caspase 3 positivity 
In order to quantify the level of tumour cell death I developed a method using 
the Volocity 3D image analysis software. The percentage tumour cell death was 
calculated as the cleaved caspase 3 positive tumour volume normalized to the 
total tumour volume. At least 10 tumours were analysed for each genotype. 
 
2.4 Protein Analysis 
2.4.1 Protein Extraction 
For Immunoprecipitation experiments 40-60 flies were homogenized in 500ul of 
10 mM Tris-HCl, 5mM EDTA, 150mM NaCl, 40mM Sodium pyrophosphate, 1% NP-
40, 0.5% sodium deoxycholate, 50 mM NaF, 1 mM sodium orthovanadate, 0.025% 
SDS, 0.5 mg/ml PMSF, and Protease Inhibitors Complete cocktail (Roche 
Molecular Biochemicals). Samples were centrifuged 12,000g for 10 mins to pellet 
adult cuticle debris and the supernatant was transferred to a fresh 
eppendorf.   Protein was quantified using micro BCA Protein assay kit (Pierce).  
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2.4.2 Immunoprecipitation 
1mg of protein sample was incubated with 40µl GFP-trap beads (Chromotek) 
overnight with rotation at 4°C. Beads were washed 3 times with homogenization 
buffer. Samples were then boiled at 95°C to release the attached protein in 35µl 
of loading dye (2xSDS buffer: 50mM TrisCl pH 6.8, 0.01% Bromophenol Blue, 4% 
SDS, 12% glycerol, 0.1M DTT) for 10mins.   
 
2.4.3 SDS-PAGE and Protein Transfer 
Protein extracts were either loaded onto a 10% polyacrylamide gel with a 4% 
stacking gel or onto a 4-12% Bis Tris pre-cast gel (Invitrogen) and run at 150V for 
1 hr in 1X NuPAGE® MOPS SDS running buffer using Invitrogen XCell SureLock™ 
electrophoresis system. 10µl of pre-stained marker (BIO-RAD Precision Plus 
Protein™ Dual Color Standard) was used to estimate protein size. Gels were 
transferred onto PDVF membrane (Amersham) and blocked with 5% Milk powder 
TBS-T for 1hr at room temperature. Membranes were incubated with primary 
antibody overnight at 4°C with shaking. Membranes were then washed 3 times 
for 10 minutes with TBS-T. Incubation with secondary antibody was performed at 
room temperature for 1 hour. Membranes were washed as described and bands 
were visualized using ECL solutions (Amersham).  
 
2.4.4 Liquid Chromatography mass spectrometry 
The samples generated from in gel digestion performed by the laboratory of Dr 
Sara Zanivan contain tryptic peptides that span a broad range of abundances. To 
measure them with high accuracy and depth, they combine the high resolving 
power of reverse phase chromatography with the speed and ultra-high resolution 
achieved in the Orbitrap Elite (Michalski et al., 2012). Data were acquired using 
the Xcalibur software, which generates .RAW files that were analyzed with the 
MaxQuant computational package (Cox and Mann, 2008). Using this analysis, they 
were able to identify 23 unique peptides corresponding to dp120ctn. 
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2.5 RNA Quantification 
2.5.1 RNA extraction from guts 
Total RNA was extracted from 6 to 10 midguts per biological replicate. RNA was 
extracted from each genotype in triplicate. A standard TRIZOL protocol was used 
to extract RNA that was then treated with DNaseI (Qiagen) to remove any 
genomic DNA. Phenol-Chloroform extraction was used to purify RNA followed by 
Ethanol precipitation. RNA was quantified using a NanoDrop Spectrophotometer.  
 
2.5.2 RNA extraction from whole flies, larval tumours and fat bodies 
Total RNA was extracted from triplicates of 10 adult females using the Qiagen 
RNAeasy kit (Qiagen) according to manufacturers instructions.   
 
2.5.3 cDNA synthesis 
cDNA synthesis was performed in triplicate for each biological replicate using 
the High-Capacity cDNA reverse transcription kit (Applied Biosystems – Life 
Technologies) from 1µg RNA. cDNA synthesis reactions were pooled for each 
biological replicate.  
 
2.5.4 Quantitative PCR 
Expression of the target genes was measured relative to that of RpL32, GAPDH 
or Actin and primers used for qPCR are shown in Table 2.3.  A series of 10-fold 
dilutions of an external standard was used in each run to produce a standard 
curve.  MAXIMA SYBR GREEN Master Mix (Fermentas) was used for gut samples 
and Quanta SYBR green Master mix (low ROX) was used for whole fly, tumour 
and fat body samples following manufacturers instructions.  Data were extracted 
and analysed using Applied Biosystems 7500 software version 2.0. Melt curves 
were used to ensure only one product was produced from each primer pair.    
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2.5.5 Primers 
Target Primer name Sequence 5'-3' 
RpL32 RpL32 F AGGCCCAAGATCGTGAAGAA  
  RpL32 A TGTGCACCAGGAACTTCTTGAA 
Unpaired updF CCACGTAAGTTTGCATGTTG 
  updR CTAAACAGTAGCCAGGACTC 
Unpaired2 upd2F ACTGTTGCATGTGGATGCTG 
  upd2R CAGCCAAGGACGAGTTATCA 
Unpaired3 upd3F AGGCCATCAACCTGACCAAC 
  upd3R ACGCTTCTCCATCAGCTTGC 
Actin act5cF1 GAGCGCGGTTACTCTTTCAC 
  act5cR1 CCATCTCCTGCTCAAAGTCG 
Drosomycin drosF1 CTCTTCGCTGTCCTGATGCT 
  drosR1 ACAGGTCTCGTTGTCCCAGA 
Pvf1 pvf1F1 CAGACCGTTCACCATCATCA 
  pvf1R1 AATCCTTGCGATACGACTGG 
Puckered pucF1 CATCTCGCCCAATCTGAACT 
  pucR1 CCCACAGAAGATGACGAAGG 
socs36E socs36EF1 ATGACCGTGCACTCGCAAAT 
  socs36ER1 CCTCGTAGCGGTCCATCTTG 
Insulin receptor  InRF1 GGTGCTGGCATCATAGGTCT 
  InRR1 CCTGCCTCTGAGTGATAGAAGG 
thor thorF1 CCAGGAAGGTTGTCATCTCG 
  thorR1 TGAAAGCCCGCTCGTAGATA 
Defensin DefF1 CTTCGTTCTCGTGGCTATCG 
  DefR1 ATCCTCATGCACCAGGACAT 
Metchnikowin MtkF1 GCTACATCAGTGCTGGCAGAG 
  MtkR1 TAAATTGGACCCGGTCTTGG 
Mmp1 Mmp1F1 ACGAGTTCGGTCACTCCTTG 
  Mmp1R1 CTTGTCGTCCTCGTCCAACT 
Spitz spitzF TACCAGGCATCGAAGGTTTC 
  spitzR GACCCAGGCTCCAGTCACTA 
Vein veinF GTGAAGTTGCCTGGATTCGT 
  veinR CTACAGGGAGCGACTGATGC 
Keren kerenF CGAGCCATCAATCTCCTTGT 
  kerenR AACGATGGCACCTGCTTTAC 
Hsp22 hsp22F1 CCGTCAACAAGGATGGCTAC 
  hsp22R1 CTCTGATTTTCCCTCCACCA 
Attacin A AttAF1 ATGCTCGTTTGGATCTGACC 
  AttAR1 AAAGTTCCGCCAGTTGTGAC 
Attacin B AttBF1 GTCATGGTGCCTCTTTGACC 
  AttBR1 CCAGATTGTGTCTGCCATTG 
Attacin C AttCF1 CAACGGTGTTCACAATCTGG 
  AttCR1 GGGAGTAGTCCAGTGCAGCTT 
Attacin D AttDF1 AGTGGGGGTCACTAGGGTTC 
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  AttDR1 GTGGCGTTGAGGTTGAGATT 
Diptericin B DptBF1 GGATTCGATCTGAGCCTCAAC 
  DptBR1 ATAGGGTCCACCAAGGTGCT 
PGRP-LB PGRP-LB-F1 TCTCCAATCTCCGATCAGCA 
  PGRP-LB-R1 GCGATGGCATGATTTACACC 
PGRP-LC PGRP-LC-F1 CCGAAGCGGAGGATTATACG 
  PGRP-LC-R1 GGCGACTGATCACCGTTAGA 
PGRP-SB PGRP-SB1-F1 AGACGATGCCAATGCTCTTG 
  PGRP-SB1-R1 ACTTTATCGTGGCCGGTGAT 
PGRP-SC PGRP-SC2F1 CGTGACCATCATCTCCAAGTC 
  PGRP-SC2R1 GTAGTTTCCAGCGGTGTGGT 
PGRP-SD PGRP-SD-F1 CAGCTGGTGGAGGGCTATAA 
  PGRP-SD-R1 AGTTGGGCCACTGCTGTATC 
Spn4 Spn4F1 TCTGGGCGGGTTAAGTGTTT 
  Spn4R1 CTTGTGCCGGCTGATGTATT 
Table 2.3:  Primer pairs used in this study 
 
2.5.6 Microarray analysis 
RNA extracted as described in 2.3.2 was sent to the MIAMI microarray facility at 
the University of Manchester were after quality control testing it was hybridized 
to the Drosophila Affymetrix chip 2.0. The cel files normalised and analysed in 
Partek Genomics Suite Software by the Beatson Bioinformatics department. RMA 
normalisation and log2 transformation of the data was followed by the 
differential gene expression analysis using t-test. All p-values were corrected for 
multiple testing using Benjamini & Hochberg step up method that controls the 
false discovery rate. Finally, the fold change values were considered in ranking 
genes of interest. 
 
2.5.6.1 Gene enrichment analysis 
Gene set enrichment analysis was done using The Database for Annotation, 
Visualization and Integrated Discovery (DAVID) version 6.7 (Huang et al., 2008). 
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2.6 Statistics 
Unless otherwise stated all experiments have been performed 3 times. All 
Statistical analyses were performed using Graph Pad Prism 6. Specific statistical 
tests are described in each figure legend. P-values less than 0.05 were 
considered statistically significant. Error bars mean ± standard error of the mean 
(SEM).  For survival experiments median survival was calculated by Graph Pad 
Prism 6 and is an approximation to the closest sampling time.  
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3 Drosophila p120 catenin: a role in the stress 
response  
3.1 Summary 
p120ctn is the founding member of the p120ctn family of proteins. It is a 
ubiquitously expressed core component of adherens junctions and has been 
shown to be essential for adherens junction formation and stability in 
mammalian epithelia. It is essential for vertebrate development and is 
deregulated in many epithelial cancers.  In Drosophila, there is only one p120ctn 
family member: dp120ctn. dp120ctn is not required for the formation of 
adherens junctions, development or homeostasis. dp120ctn null flies are viable 
and fertile and display no obvious phenotype. As this gene family is well 
conserved from invertebrates to vertebrates I hypothesized that although not 
essential for development dp120ctn may be required in certain conditions. To 
test this I assayed the requirement of dp120ctn in stress and oncogenic stress 
conditions. I found that dp120ctn null adult flies were sensitive to Heat shock 
and display a reduced lifespan that can be rescued by ubiquitous overexpression 
of dp120ctn. Using transcriptomic analysis I analysed normal and stress induced 
transcription and found that several targets of the relish/NF-κB transcription 
factor were differentially expressed. This aberrant gene expression was rescued 
by overexpression of dp120ctn and heterozygosity for relish. 
 I also examined the effects of dp120ctn loss on tumour burden in null 
mutants of the scribble group of polarity tumour suppressors.  I found that 
tumour burden was increased in larvae carrying both mutations. I have carried 
out a preliminary analysis on this model and suggest further experiments to 
understand the role of dp120ctn in this tumour model.     
Together these results indicate that dp120ctn may negatively regulate 
immune signalling in adult flies and suggests that loss of dp120ctn in 
transformed epithelia may increase tumour burden. This novel role of dp120ctn 
in the regulation of immune signalling may be the ancestral role of dp120ctn.  
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3.2 Introduction 
3.2.1 Adherens Junctions 
Adherens junctions are cell-cell adhesive junctions, that are centrally required 
for normal epithelial architecture and their dynamic regulation is pivotal for the 
development of tissues, organs and animals. Adherens junctions are made up of 
several different proteins that orchestrate adhesion between cells. Adherens 
junctions are formed when the extracellular domain or ectodomain of classical 
cadherins trans-dimerizes with that of an adjacent cell. The cadherin 
cytoplasmic tail contains a catenin binding domain (CBD) and a highly conserved 
juxta-membrane domain (JMD) which participates in cytoskeletal organization 
and intracellular signalling (Takeichi et al., 2000).  Catenins, α- and β-catenin 
work in concert to link the intracellular domain of classical cadherins to the 
actin cytoskeleton regulating cell-cell adhesion (Anastasiadis and Reynolds, 
2000).  α-catenin binds β-catenin which itself binds to the CBD domain of 
cadherin and the actin cytoskeleton to tether the junction. p120ctn binds 
cadherin at the JMD domain and regulates the strength of adhesion.  
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3.2.2 p120 catenin 
p120 catenin (p120ctn) was first characterized as part of a screen for 
phosphorylated substrates of the transforming tyrosine kinase, Src (Reynolds et 
al., 1989). p120 catenin is the ubiquitously expressed prototypic member of the 
p120ctn family which includes ARCVF; p0071 and δ-catenin. The remaining 
members of the family are expressed at lower levels (Anastasiadis et al., 2000). 
p120ctn binds the highly conserved juxta-membrane domain (JMD) of classic 
cadherins to promote adherens junction stability (Reynolds et al., 1989, 
Reynolds et al., 1994, Anastasiadis et al., 2000). 
 
3.2.3 Structure and function 
p120ctn localizes to the plasma membrane, cytoplasm and nucleus. Human 
p120ctn has 4 alternative start codons which define four isoforms, p120 1 – 4 
(Ishiyama et al., 2010). Through alternative splicing of 4 alternative exons, a 
total of 48 possible isoforms can be produced (Ishiyama et al., 2010). The 
protein is composed of three main domains, an N-terminal regulatory domain, 
nine Armadillo (ARM) repeats and a C-terminal domain.  The N-terminal 
regulatory domain contains serine/threonine and tyrosine phosphorylation sites 
that are acted upon by Src family kinases (SFK), tyrosine phosphatases (PTP) and 
Serine/Threonine Kinases (Xu et al., 2004, Zondag et al., 2000) to regulate 
p120ctn function. At the plasma membrane, p120ctn binds E-cadherin at the 
JMD through its ARM repeats. This interaction can be abolished through 
modification of two conserved glycine residues contained within the JMD 
(Thoreson and Reynolds, 2002, Ishiyama et al., 2010).  β-catenin binds E-
cadherin at the CBD and is then itself bound by α-catenin which anchors the 
complex directly to the actin cytoskeleton (Reynolds, 2007). While the 
connection to the actin cytoskeleton via β-catenin and α-catenin is essential for 
cadherin-dependent adhesion, the role of p120ctn is not (Reynolds et al., 1994, 
Daniel and Reynolds, 1995, Anastasiadis et al., 2000, Ireton et al., 2002, Smith 
et al., 2012). In the absence of p120ctn, E-cadherin is endocytosed resulting in 
weaker adhesion as junctions become more dynamic (Thoreson et al., 2000, 
Ireton et al., 2002, Pece and Gutkind, 2002).  Moreover, binding of p120ctn to 
the JMD of classic cadherins prevents modifications that target cadherins for 
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degradation (Fujita et al., 2002). Thus, p120ctn can modulate the strength of 
adhesion.  
In the cytoplasm, p120ctn has been shown to regulate Rho GTPases and 
exert effects on actin fiber contractility (Anastasiadis et al., 2000, Anastasiadis 
and Reynolds, 2001, Fang et al., 2004).  
p120ctn associates with the BTB/POZ transcriptional repressor Kaiso and 
affects its localization and role in the regulation of transcription (Daniel and 
Reynolds, 1999, Van Roy and Mccrea, 2005, Daniel, 2007, Dai et al., 2010, Zhang 
et al., 2010, Zhang et al., 2011, Jones et al., 2012, Jiang et al., 2012). Kaiso 
also associates with β-catenin preventing transcription downstream of Wnt 
signalling activation. When Wnt signalling is induced p120ctn becomes 
phosphorylated and this increases its affinity for Kaiso. When p120ctn is bound 
β-catenin is free to drive transcription (del Valle-Pérez et al., 2011).  
 
3.2.4 p120ctn in development  
In order to understand p120ctn function in vivo it has been deleted or 
downregulated in many different models.  In C. elegans knockdown of the 
p120ctn homologue JAC-1 has no measurable effects on development but is 
believed to be a positive regulator of adherens junctions (Pettitt et al., 2003). In 
Xenopus, miss-expression of p120ctn or concomitant knockdown together with δ-
catenin leads to gastrulation defects (Paulson et al., 1999, Gu et al., 2009). In 
the mouse, a p120ctn knock out (KO) was lethal. Using conditional knockout 
models p120ctn has been shown to be required for salivary gland, brain, kidney, 
vascular and mammary gland development (Davis and Reynolds, 2006, Elia et al., 
2006, Oas et al., 2010, Marciano et al., 2011, Kurley et al., 2012).   
 
3.2.5 p120ctn in Cancer 
p120ctn is downregulated, mislocalized or misexpressed in many different 
cancers and correlates with poor prognosis and survival. (Thoreson and Reynolds, 
2002, Mayerle et al., 2003, Fei et al., 2009, Vidal et al., 2010, Mortazavi et al., 
2010, Talvinen et al., 2010, Miao et al., 2010, Lu, 2010, Dai et al., 2011).  
p120ctn is a bona fide tumour suppressor in the mouse oesophageal tract and its 
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deletion results in the establishment of an inflammatory microenvironment. In 
the mouse intestine, conditional knockdown of p120ctn leads to inflammation 
and an increased adenoma formation and in the mouse epidermis deletion of 
p120ctn increases inflammation and tumourigenesis (Perez-Moreno et al., 2006, 
Perez-Moreno et al., 2008, Smalley-Freed et al., 2011, Smalley-Freed et al., 
2010).   
 
3.2.6 Drosophila p120 catenin 
Drosophila p120ctn (dp120ctn) is the single member of the p120ctn family in 
flies and is ubiquitously expressed with enrichment in the larval and adult 
central nervous system (CNS) (FlyAtlas.org). The gene contains 4 exons across 
around 14Kb that gives rise to a 781 amino acid (aa) protein with an approximate 
molecular weight of 87kDa (Myster et al., 2003). dp120ctn localizes to the 
cytoplasm and plasma membrane (Myster et al., 2003, Pacquelet et al., 2003). In 
the cytoplasm it binds and possibly has an inhibitory role on Rho1, the 
Drosophila homologue of the Rho GTPase RhoA, as it preferentially binds to the 
GDP bound form of Rho1 and could block GDP-GTP exchange keeping the protein 
inactive (Magie et al., 2002). At the plasma membrane dp120ctn localizes to 
adherens junctions where, like its vertebrate counterpart, it binds to the 
conserved JMD of DE-cadherin but in Drosophila this interaction does not affect 
DE-cadherin stability (Pacquelet et al., 2003, Myster et al., 2003). Initial 
experiments using direct injection of dsRNA against dp120ctn into embryos 
suggested an essential function for dp120ctn (Magie et al., 2002) and there have 
been reports of mild developmental defects in the developing retina (Larson et 
al., 2008). Nevertheless, the generation of a null allele for dp120ctn through 
incomplete P-element excision demonstrated that dp120ctn is dispensable for 
development and homeostasis in Drosophila (Myster et al., 2003). This finding 
was further confirmed when re-expression of a mutant dE-cadherin (dE-cad) that 
cannot bind dp120ctn rescued shotgun/DE-cadherin null mutants (Pacquelet et 
al., 2003). This is in great contrast with the observation that null mutations of 
either Armadillo (β-catenin) or Shotgun (dE-cad) result in gastrulation defects. 
Combination of either of these null mutants with loss of dp120ctn greatly 
enhanced the lethality of these alleles mutations suggesting that dp120ctn may 
not have an essential role in adhesion but might be required to modulate it 
	   60 
(Myster et al., 2003). There have been no homologous proteins identified for 
Kaiso in Drosophila and as dp120ctn has not yet been reported to localize to the 
nucleus it is still unknown if dp120ctn plays are role in the nucleus.  Despite this 
dispensability of dp120ctn for adhesion, it has been retained in the Drosophila 
genome and can be found in all invertebrates and vertebrates as a single or 
multi-gene family. This suggests that it may have important ancestral roles 
(Zhao et al., 2011, Carnahan et al., 2010).  
 
3.2.7 Aims of project 
Due to the requirement of p120ctn for development in vertebrate models open 
questions remain about adhesion independent functions of p120ctn. I 
hypothesized that as dp120ctn was not required for development in Drosophila 
this would be a tractable model to uncover novel adhesion independent roles of 
p120ctn. I wanted to address if dp120ctn could be required in conditions of 
stress and to incorporate loss of dp120ctn with genetically defined models of 
Cancer in Drosophila in order to study the affect on tumour burden. 
The majority of the experiments were carried out by myself.  I would like to 
acknowledge assistance from Karen Strathdee with troubleshooting of the IP 
protocol and from Christin Bauer a visiting student who carried out the salt and 
H2O2 stress tests and helped with qPCR. 
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3.3 Results 
3.3.1 dp120ctn mutants are not sensitive to oxidative stress 
I hypothesized that while dispensable for development and adult tissue 
homeostasis, dp120ctn could be required in conditions of stress in adult flies. To 
ensure that I only observed phenotypes associated specifically with loss of 
dp120ctn I initially backcrossed flies carrying the null allele of dp120ctn, 
p120ctn308 with the control background w1118 for ten generations to create our 
experimental line (w1118; p120308) (O'Keefe et al., 2007). For all experiments we 
compared mated w1118 male and females with mated w1118; p120308 males and 
females. 
Oxidative stress is characterized as an increase in the amount of reactive 
oxygen species (ROS) in a biological system and has been linked to several 
pathologies.  In order to induce oxidative stress in our system I treated flies with 
either Paraquat (Sigma) or H202 (Sigma). Paraquat is a herbicide that is readily 
reduced in cells to give rise to ROS, while H202 is a potent ROS itself.  To 
examine the effects of oxidative stress on controls and dp120ctn mutants, I fed 
overnight starved 7 day old adults with either 20µM Paraquat 5% sucrose or 1% 
H202 5% sucrose media. These concentrations were chosen as both had been 
previously demonstrated to induce oxidative stress in Drosophila. I compared the 
survival of controls (w1118 -blue line) and dp120ctn mutants (w1118; p120308-red 
line) on these two media. I found no difference in survival associated with loss 
of dp120ctn in males or females on either Paraquat or H202  (Fig 3.1A-B and Fig 
3.2A-B). 
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Figure 3.1  dp120ctn mutants flies are not sensitive to Paraquat  
(A-B) Survival of w1118 and w1118; p120308 males (A) and females (B) fed a 
sucrose solution containing 20µM Paraquat. Survival is plotted as adult survival in 
hours at 25°C. Blue lines indicate w1118 controls and red lines w1118; p120308.  
Each curve represents ~100 flies. Median survival is presented for each cohort 
and p value generated using log-rank tests. 
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Figure 3.2 dp120ctn mutants are not sensitive to H2O2  
(A-B) Survival of w1118 and w1118; p120308 males (A) and females (B) on a 1% H2O2, 
5% Sucrose agar medium. Survival is plotted as adult survival in hours at 25°C. 
Blue lines indicate w1118 controls and red lines w1118; p120308.  Each curve 
represents ~100 flies. Median survival is presented for each cohort and p value 
generated using log-rank tests.  
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3.3.2 dp120ctn mutants are not sensitive to osmotic stress 
Osmotic stress results in acute changes in water balance. To understand whether 
dp120ctn mutants were more sensitive to an increase in osmotic stress I added 
sodium chloride (NaCl, Sigma) at a concentration of 6% to normal fly medium 
and then fed overnight starved 7 day old control (w1118) and dp120ctn (w1118; 
p120308) males and females on this media. This concentration of NaCl was chosen 
as it had been previously been shown to induce acute osmotic stress 
(Stergiopoulos et al., 2009). I observed that there was a significant difference in 
survival between control (w1118 -blue line) and dp120ctn mutant males (w1118; 
p120308-red line) (Fig 3.3A) but this was not mirrored in the case of females 
which showed no change in median survival in these conditions (Fig 3.3B). These 
results suggested that dp120ctn males were sensitive to increased osmotic stress 
but females were not.  
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Figure 3.3 dp120ctn mutants are not sensitive to osmotic stress  
(A-B) Survival of w1118 and w1118; p120308 males (A) and females (B) on standard 
medium supplemented with 6% NaCl. Survival is plotted as adult survival in hours 
at 25°C. Blue lines indicate w1118 controls and red lines w1118; p120308.  Each 
curve represents ~100 flies. Median survival is presented for each cohort and p 
value generated using log-rank tests.  
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3.3.3 dp120ctn mutants are sensitive to heat shock 
Heat shock, where an organism is exposed to temperatures out with normal 
ambient temperature has been heavily studied and is often used to induce stress 
conditions. It acts as a stress stimulus that induces transcription of specific 
genes, namely the Heat Shock proteins. A number of these genes encode protein 
chaperones that assist with protein folding, localization and targeting of old or 
misfiled proteins for degradation. Like most invertebrates, Drosophila is unable 
to regulate body temperature and as such prefers temperatures ranging from 
18ºC to 29ºC. To induce Heat shock, I placed control and dp120ctn mutant flies 
in a 37ºC water bath. I placed 7 day old flies in empty vials to prevent flies 
sticking to the food and dying during the experiment. The vials were submerged 
in order to ensure a constant temperature of the 37ºC inside the vials. The vials 
were removed every 15 minutes so that the number of dead flies could be 
scored. We compared the survival of control males and females (w1118 -blue line) 
to dp120ctn mutant males and females (w1118; p120308-red line). We found that 
both dp120ctn males and females were significantly more sensitive to heat shock 
stress with nearly a 50% decrease in median survival under these conditions (Fig 
3.4A-B).  This suggests that dp120ctn may be functionally required under heat 
shock stress conditions. 
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Figure 3.4 dp120ctn mutants are sensitive to heat shock 
(A-B) Survival of w1118 and w1118; p120308 males (A) and females (B) under heat 
shock conditions. Survival is plotted as adult survival in minutes under heat 
shock at 37°C. Blue lines indicate w1118 controls and red lines w1118; p120308.  
Each curve represents ~100 flies. Median survival is presented for each cohort 
and p value generated using log-rank tests. 
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3.3.4 dp120ctn mutants are sensitive to starvation 
Animal starvation results in progressive tissue degradation and, if prolonged 
indefinitely, in death. I wanted to examine whether dp120ctn mutant flies were 
more sensitive to starvation. To induce starvation, I placed 7 day old control and 
dp120ctn mutant males and females in vials containing 5ml of 1% Agar 
(Detacher) at 25ºC. The agar did not contain any caloric value but was utilized 
to maintain moisture levels within the vial to prevent desiccation. We measured 
the survival of control males and females (w1118 -blue line) to dp120ctn mutant 
males and females (w1118; p120308-red line) and found that both dp120ctn mutant 
males and females were significantly more sensitive to starvation at 25ºC with -
nearly a 20% decrease in median survival under these conditions (Fig 3.5A-B).  
This suggests that dp120ctn may be required during starvation stress. 
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Figure 3.5  dp120ctn mutants are sensitive to starvation 
(A-B) Survival of w1118 and w1118; p120308 males (A) and females (B) under 
Starvation conditions. Survival is plotted as adult survival in hours under 
Starvation at 25°C. Blue lines indicate w1118 controls and red lines w1118; p120308.  
Each curve represents ~100 flies. Median survival is presented for each cohort 
and p value generated using log-rank tests. 
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3.3.5 dp120ctn mutants have a reduced median lifespan 
Ageing is characterized by a progressive deterioration of an animal. One 
consequence of the ageing process is a reduced ability to cope with 
environmental stress. To ascertain whether dp120ctn mutants were less able to 
deal with environmental stress and thus may have a reduced lifespan I measured 
the lifespan of control and dp120ctn mutant males and females. I collected flies 
within 12hrs of eclosion to reduce variability. I allowed them to mate for 48 hrs 
as mated flies are normally used in this type of analysis as female virgin have a 
different physiology than mated females (Cognigni et al., 2011). Lifespan 
analysis at 29ºC is often used as an accelerated assay. In accordance with this I 
first measured lifespan of dp120ctn mutants in these conditions. We observed a 
significant decrease in median lifespan of dp120ctn mutants (w1118; p120308-red 
line) when compared with control flies (w1118 -blue line) and this was consistent 
in males and females (Fig 3.6A-B).  These results were encouraging and to 
extend them I repeated the experiment at 25ºC. When I measured lifespan of 
dp120ctn mutant males and females (w1118; p120308-red line) at 25ºC I found that 
they displayed a reduced median survival when compared to controls (w1118 -blue 
line)  (Fig 3.7A-B). Additionally, I observed a small but reproducible decrease in 
the maximum lifespan of dp120ctn mutant males and females (Fig 3.87-B).   This 
together with what we had observed at 29ºC suggested that dp120ctn maybe 
required for normal lifespan even in conditions were the flies were not being 
exposed to an acute stress stimulus. 
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Figure 3.6 dp120ctn mutants display a reduced lifespan at 29°C  
(A-B) Lifespan of w1118 and w1118; p120308 males (A) and females (B) at 29°C. 
Survival is plotted as adult survival in days. Blue lines indicate w1118 controls and 
red lines w1118; p120308.  Each curve represents ~100 flies. Median survival is 
presented for each cohort and p value generated using log-rank tests.  
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Figure 3.7 dp120ctn mutants display a reduced lifespan at 25°C 
Lifespan of w1118 and w1118; p120308 males (A) and females (B) at 25°C. Survival is 
plotted as adult survival in days. Blue lines indicate w1118 controls and red lines 
w1118; p120308.  Each curve represents ~100 flies. Median survival is presented for 
each cohort and p value generated using log-rank tests.  
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3.3.6 Ubiquitous expression of dp120ctn-GFP rescues heat shock 
sensitivity in dp120ctn mutants 
As I had isogenized dp120ctn null mutants (p120308) by backcrossing them to the 
control strain I was confident that the stress sensitivity I had observed was a 
result of the absence of dp120ctn.  Nevertheless, to further confirm this I 
attempted to rescue the stress sensitivity phenotype of dp120tn mutants by re-
expressing dp120 in these mutants. To do this I used a fly expressing a GFP 
tagged form of dp120ctn under the control of the ubiquitin promoter (ubi-p120-
GFP) (Myster et al., 2003), which I also backcrossed to the w1118 strain and 
combined with the dp120ctn null allele (w1118; p120308; ubiquitin-p120-GFP).  
I first tested if I could rescue the sensitivity to heat shock of dp120ctn 
mutants. I repeated the experiment as before but with the addition of dp120ctn 
mutant flies that were also expressing dp120ctn-GFP ubiquitously (w1118; p120308; 
ubi-p120-GFP). When I exposed control (w1118-blue line), dp120ctn mutant (w1118; 
p120308-red line) and rescue (w1118; p120308; ubi-p120-GFP-green line) males and 
females to heat shock at 37°C, I observed that expression of dp120ctn-GFP 
completely rescued the sensitivity to heat shock observed in dp120ctn mutants 
(Fig 3.8A-B). Thus confirming that the heat shock sensitivity I observed in 
dp120ctn mutants is specific to loss of dp120ctn. 
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Figure 3.8 Ubiquitous Expression of p120-GFP rescues sensitivity to heat 
shock in dp120ctn flies 
(A-B) Survival of w1118, w1118; p120308 and w1118; p120308; ubi-p120-GFP males (A) 
and females (B) under heat shock conditions. Survival is plotted as adult survival 
in minutes under heat shock at 37°C. Blue lines indicate w1118 controls, red lines 
w1118; p120308 and green lines w1118; p120308; ubi-p120-GFP.  Each curve 
represents ~100 flies. Median survival is presented for each cohort and p values 
generated using log-rank tests (Green p values correspond to comparison 
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between w1118; p120308 (RED) and w1118; p120308; ubi-p120-GFP (GREEN), blue p 
values correspond to comparison between w1118; p120308 (RED) and w1118 (BLUE)). 
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3.3.7 Ubiquitous expression of dp120ctn-GFP partially rescues starvation 
in dp120ctn mutant females. 
I next tested if I could rescue the sensitivity of dp120ctn mutants to starvation. I 
measured survival under starvation in control (w1118-blue lines), dp120ctn mutant 
flies (w1118; p120308-red lines) and dp120ctn mutant flies that also express 
dp120ctn-GFP ubiquitously (w1118; p120308; ubiquitin-p120-GFP-greed lines). I 
observed that expression of dp120ctn-GFP failed to rescue starvation sensitivity 
of dp120ctn mutant males as rescue males had a median survival similar to 
dp120ctn mutant males (Fig 3.9A). When I looked at survival of female rescue 
flies I observed an intermediate rescue of median survival under starvation (Fig 
3.9B).  In this case expression of dp120ctn-GFP was not able to rescue stress 
sensitivity in dp120ctn mutants. 
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Figure 3.9 Ubiquitous Expression of p120-GFP partially rescues starvation 
sensitivity in female dp120ctn but not male dp120ctn mutant flies. 
(A-B) Survival of w1118, w1118; p120308 and w1118; p120308; ubi-p120-GFP males (A) 
and females (B) under starvation conditions. Survival is plotted as adult survival 
in hours under starvation at 25°C. Blue lines indicate w1118 controls, red lines 
w1118; p120308 and green lines w1118; p120308; ubi-p120-GFP.   Each curve 
represents ~100 flies. Median survival is presented for each cohort and p value 
generated using log-rank tests (Green p values correspond to comparison 
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between w1118; p120308 (RED) and w1118; p120308; ubi-p120-GFP (GREEN), blue p 
values correspond to comparison between w1118; p120308 (RED) and w1118 (BLUE), 
ns-non significant).  
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3.3.8 Ubiquitous expression of dp120ctn-GFP rescues lifespan reduction in 
dp120ctn mutants 
I also wanted to examine whether the reduction in median survival observed in 
dp120ctn mutants maintained at 25ºC and 29ºC could be rescued by ubiquitous 
expression of dp120ctn-GFP. When I compared the survival curves of control 
males and females (w1118-blue lines) with dp120ctn mutant (w1118; p120308-red 
lines) males and females I again observed a significant reduction in median 
lifespan at both 29ºC and 25ºC (Fig 3.10A-B and Fig 3.11A-B).  However, when I 
compared control flies (w1118-blue line) with dp120ctn mutant males and females 
that were also expressing dp120ctn-GFP ubiquitously (w1118; p120308; ubiquitin-
p120-GFP -green lines) I found that median lifespan was similar to controls at 
29ºC and 25ºC (Fig 3.10A-B and Fig 3.11A-B). This confirmed that the reduction 
in median and maximum lifespan I observed in dp120ctn mutants was specific to 
loss of dp120ctn. 
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Figure 3.10 Ubiquitous Expression of p120-GFP rescues reduced lifespan of 
dp120ctn mutant flies at 29°C. 
(A-B) Lifespan of w1118, w1118; p120308 and w1118; p120308; ubi-p120-GFP males (A) 
and females (B) at 29°C. Blue lines indicate w1118 controls, red lines w1118; 
p120308 and green lines w1118; p120308; ubi-p120-GFP.  Each curve represents ~100 
flies. Median survival is presented for each cohort and p value generated using 
log-rank tests (Green p values correspond to comparison between w1118; p120308 
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(RED) and w1118; p120308; ubi-p120-GFP (GREEN), blue p values correspond to 
comparison between w1118; p120308 (RED) and w1118 (BLUE)).  
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Figure 3.11 Ubiquitous Expression of p120-GFP rescues reduced lifespan of 
dp120ctn mutant flies at 25°C. 
(A-B) Lifespan of w1118, w1118; p120308 and w1118; p120308; ubi-p120-GFP males (A) 
and females (B) at 25°C. Blue lines indicate w1118 controls, red lines w1118; 
p120308 and green lines w1118; p120308; ubi-p120-GFP.  Each curve represents ~100 
flies. Median survival is presented for each cohort and p value generated using 
log-rank tests (Green p values correspond to comparison between w1118; p120308 
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(RED) and w1118; p120308; ubi-p120-GFP (GREEN), blue p values correspond to 
comparison between w1118; p120308 (RED) and w1118 (BLUE)).  
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3.3.9 dp120ctn-GFP specifically delocalizes upon heat shock 
To address how dp120ctn might be affected by stress stimuli I utilized dp120ctn-
GFP to analyse localization of the dp120ctn in the Drosophila intestinal 
epithelium. I chose to perform this experiment in this tissue, as the adult 
intestine is a monolayered epithelium that is easily dissected and contains a 
variety of differentiated and undifferentiated cells. I dissected midguts from 
dp120ctn mutant flies expressing dp120ctn-GFP (w1118; p120308; ubi-p120-GFP) 
before and after 1 hour heat shock at 37°C.  I used this genotype so that all the 
dp120ctn present would be tagged with GFP and to avoid reaching toxic levels of 
dp120ctn protein. Before heat shock dp120ctn-GFP was localized mostly at the 
plasma membrane with a diffuse cytoplasmic signal (Fig 3.12A-A’’, white arrow). 
After heat shock dp120ctn-GFP could no longer be found at the plasma 
membrane of cells and instead the signal was diffuse and cytoplasmic (Fig 3.12B-
B’’, white arrow). This could be best appreciated in small cells where the 
cytoplasmic signal was more intense (Fig 3.12B-B’’). 
 This result was very interesting but I wanted to test if it was specific as 
delocalization of dp120ctn upon heat shock could result from adherens junction 
disassembly.  To address this point I repeated the experiment and stained for 
the core component armadillo (arm/β-catenin). Before heat shock I could 
observe that Arm was localized to cell membranes together with dp120ctn-GFP 
(Fig 3.13A-A’’, white arrows). After heat shock, arm was still localized to 
membranes but as I had previously observed dp120ctn-GFP was delocalized and 
appeared diffuse in the cytoplasm (Fig 3.13B-B’’, white arrows).  
 From these experiments I can say that dp120ctn-GFP becomes specifically 
delocalized from the plasma membrane upon heat shock and that this is not a 
result of adherens junction disassembly. 
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Figure 3.12 p120-GFP delocalizes upon Heat-shock in the Drosophila midgut 
epithelium.  
(A-B’’) Immunofluorescence of 7 day old midguts from w1118; p120ctn308; ubi-
p120ctn-GFP flies before (A-A’’) and after 1 hour heat-shock (B-B’’) stained with 
DAPI and GFP. White arrowheads highlight membrane localization of p120-GFP 
that becomes diffuse after Heat- shock. Scale bar 25µm. 
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Figure 3.13 Armadillo (β-Catenin) does not delocalize upon Heat-Shock in the 
Drosophila midgut. 
(A-B’’) Immunofluorescence of 7 day old midguts from w1118; p120ctn308; ubi-
p120ctn-GFP flies before (A-A’’) and after 1 hour heat-shock (B-B’’) stained with 
GFP and Armadillo. White arrowheads highlight membrane localization of p120-
GFP that becomes diffuse after heat-shock while Armadillo remains clearly 
localized to the plasma membrane. Scale bar 25µm. 
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3.3.10 dp120ctn-GFP is regulated upon heat shock 
I next wanted to ascertain if dp120ctn was perhaps being regulated as a result of 
heat shock and that this was leading to the delocalization I had observed. I first 
tested whether dp120ctn transcription was altered upon heat shock. I performed 
qPCR analysis on RNA from control (w1118) flies and control whole adult flies heat 
shocked at 37°C for 1 hour and measured the levels of mRNA of dp120ctn and 
the core adherens junction protein dE-cad.  I did not observe any significant 
difference in the transcription of these genes suggesting that dp120ctn is not 
regulated at the transcriptional level upon heat shock (Fig 3.14A-B).  
 Next I looked at dp120ctn regulation at the protein level using dp120ctn-
GFP. After several failed attempts to visualize dp120ctn-GFP using western blot 
analysis, I decided to use the GFP tag to perform a GFP immunoprecipitation. 
Using this technique I analyzed samples from dp120ctn rescue flies (w1118; 
p120ctn308; ubi-p120ctn-GFP) before and after heat shock treatment. The 
anticipated size of dp120ctn-GFP is around 113kDa. I observed two distinct 
bands in both samples, one at around 80kDa and one at around 130kDa (Fig 
3.14C) and as you can see from the western blot performed on the sample input 
dp120ctn-GFP was undetectable by western blot analysis (Fig 3.14D). More 
interestingly, I could see that there was more of the higher molecular weight 
band after heat shock treatment. The opposite was true for the lower molecular 
weight band that seemed to deplete after heat shock. In collaboration with the 
group of Sara Zanivan in the Beatson bands corresponding to these different 
molecular weights were cut out and using mass spectroscopy it was confirmed 
that all 4 bands contained dp120ctn-GFP (Fig 3.14C). Unfortunately due to the 
location of trypsin cleavage sites within dp120ctn we were not able to 
distinguish which regions of the protein were missing in the lower molecular 
weight band (Fig 3.14C). Overall, I concluded that two forms of dp120ctn-GFP 
are present in the cell and that heat shock affects the relative levels of these 
forms. 
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Figure 3.14 dp120ctn-GFP is regulated upon Heat shock. 
(A-B) qPCR analysis for dp120ctn (A) and dE-cad (B) in w1118 flies before and 
after Heat shock. (C) dp120ctn-GFP was immunoprecipitated using GFP-pull 
down in dp120ctn mutant flies expressing dp120ctn-GFP ubiquitously (w1118; 
p120308; ubi-p120-GFP). (D) Input was blotted for GFP ubi-p120-GFP was not 
detected using western blotting methods. 
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3.3.11 dp120ctn mutants possess a differential gene expression 
profile. 
To gain insights into the mechanisms that underlie how dp120ctn might be 
required in response to specific stressors I decided to perform microarray 
analysis on RNA extracted from control (w1118) and dp120ctn mutant (w1118; 
p120308) females.  This allowed me to get a global view of transcription in these 
mutants before and after stress stimulus. I isolated total RNA from control 
(w1118) and dp120ctn mutant (w1118; p120308) 7 day old adult female flies in 
biological triplicates before and after 1 hour Heat shock at 37°C. Samples were 
purified and then sent to the MIAMI microarray facility at the Paterson Institute 
where the samples were hybridized to the Affymetrix GeneChip platform. After 
data collection the Beatson Institute Bioinformatics facility calculated fold 
change and significance. A cut off of 1.5/-1.5 in fold change and an adjusted p-
value of 0.05 was used to select genes for analysis. 
 I first compared how each genotype responded to the 1 hour heat shock 
(Fig 3.15A). I could appreciate that although there were many genes equally 
upregulated and downregulated in response to heat shock there were also many 
genes that behaved distinctly in each genotype upon heat shock.  I found that 
overall more genes were induced than repressed in both control  (w1118) and 
dp120ctn mutant flies  (w1118; p120308) flies after eat shock (Fig 3.15B-C).  When I 
looked just at those genes that were upregulated I noted that over 60 genes 
more were upregulated in dp120ctn mutant flies  (w1118; p120308) than in control  
(w1118) flies (Fig 3.15B).  Additionally, only around half the genes induced in 
control  (w1118) and dp120ctn mutant flies  (w1118; p120308) flies were common 
between both groups. A significant number of genes were also downregulated in 
response to heat shock but in this case control (w1118) flies downregulated around 
70 genes more than dp120ctn mutant flies  (w1118; p120308) and only around half 
the genes downregulated in control (w1118) flies were also downregulated in 
dp120ctn mutant flies  (w1118; p120308) (Fig 3.15C). From this first assessment I 
could conclude that indeed there was a transcriptional response to heat shock in 
dp120ctn mutant flies  (w1118; p120308), however it did not completely match 
that of control (w1118) flies. I next wanted to ask whether dp120ctn mutant flies 
(p120308) had a distinct transcriptional profile from control flies without any 
stress stimulus as I had observed a reduction in lifespan at 29°C and 25°C which 
could be rescued by ubiquitous expression of dp120ctn-GFP (Fig 3.10 and Fig 
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3.11). When I performed this comparison I found around 700 genes that were 
differentially expressed in dp120ctn mutant flies (p120308) (Fig 3.15D).  The 
majority of genes were up- or downregulated between 1.5 and 5 fold where as 
around only 40 genes were up- or downregulated more than 5 fold in dp120ctn 
mutant flies (w1118; p120308) (Fig 3.15D).  From this, I could conclude that 
dp120ctn mutant flies possessed a differential transcriptional profile before and 
after heat shock treatment. 
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Figure 3.15 Transcriptomic analysis of dp120ctn mutants reveals differential 
gene expression. 
(A) Averaged expression profile (log2 expression values) of selected genes in 
w1118 and w1118; p120308 flies before (w1118, w1118; p120308) and after 1hr of heat 
shock (w1118-HS, w1118; p120308-HS). (B-C) Diagrams showing the number of genes 
upregulated and downregulated in w1118 and w1118; p120308 flies in response to a 
1hr heat shock, and their overlap. (D) Graph displaying the numbers of genes up-
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or down regulated in each fold change category between w1118 and w1118; 
p120308 flies   
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3.3.12 dp120ctn negatively regulates immune signalling. 
A careful examination of the data led me to realize that many of the genes that 
were differentially regulated in dp120ctn mutant flies (w1118; p120308) were 
associated with a response to infection. Going back to the literature, I identified 
two previous studies from De Gregorio et al that had investigated the 
transcriptomic response of adult flies to different immune challenges (De 
Gregorio et al., 2001, De Gregorio et al., 2002).  In these studies De Gregorio et 
al were able to identify around 400 genes that they named Drosophila immune-
regulated genes (DIRGs) as their transcription was regulated in response to 
infection with a variety of Drosophila pathogens (De Gregorio et al., 2001). They 
went on to extend this by defining which DIRGs were targets of the Immune 
deficiency pathway (IMD) or the Toll signalling pathway, that represent the two 
branches of the innate immune response in Drosophila. Each pathway is 
upstream of the NF-κB like transcription factors relish (IMD) and Dorsal/Dorsal 
related immune factor (Dif) (Toll) which act to effect transcription in order to 
respond accordingly to an immune challenge (De Gregorio et al., 2002, Lemaitre 
and Hoffmann, 2007). I found that several DIRGs were misregulated in dp120ctn 
mutant flies (w1118; p120308). To confirm these hits I performed qPCR analysis on 
from control (w1118), dp120ctn mutant flies (w1118; p120308) and dp120ctn mutant 
flies ubiquitously expressing dp120ctn-GFP (w1118; p120308; ubi-p120-GFP) before 
and after 1 hour heat shock 37°C. 
I first looked at Heat shock protein 22 (Hsp22) that is induced readily 
upon heat shock as a control. I found that all flies subjected to heat shock 
showed highly elevated levels of this gene (Fig 3.16A).  I next measured levels of 
three antimicrobial peptides (AMPs), Attacin C (AttC), Attacin D (AttD) and 
Diptericin B (DptB) that are all induced in response to infection through the IMD 
pathway downstream of relish (De Gregorio et al., 2002, Lemaitre and 
Hoffmann, 2007) (Fig 3.16B-D). In all three cases, expression of these genes in 
dp120ctn mutant flies (w1118; p120308) was significantly increased even before 
heat shock treatment (Fig 3.16B-D). Additionally, after heat shock AttC and DptB 
were significantly upregulated only in dp120ctn mutant flies (w1118; p120308) (Fig 
3.16B, D). Furthermore, this aberrant expression was completely abolished in 
dp120ctn mutant flies ubiquitously expressing dp120ctn-GFP (w1118; p120308; ubi-
p120-GFP)(Fig 3.16B-D). I also measured the levels of another DIRG, the 
peptidoglycan recognition protein (PGRP-LB) in the same samples and found that 
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dp120ctn mutant flies (w1118; p120308) expressed significantly higher levels of 
this gene before heat shock and that this misregulation was rescued in dp120ctn 
mutant flies ubiquitously expressing dp120ctn-GFP (w1118; p120308; ubi-p120-
GFP)(Fig 3.16E). This data strongly supports a role for dp120ctn in the negative 
regulation of the immune response as dp120ctn mutants express genes that are 
normally expressed as part of an immune response.  
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Figure 3.16 Ubiquitous expression of p120ctn-GFP rescues aberrant gene 
expression in dp120ctn mutant flies.  
(A-E) qPCR analysis of selected targets in w1118, w1118; p120308 and w1118; p120308; 
ubi-p120-GFP flies before and after 1hr heat shock (one-way ANOVA with 
Bonferroni post test correction, ns: non-significant, * p<0.05; **p<0.005, 
***p<0.001****p<0.0001).  Targets B-E have been reported to be regulated by the 
relish transcription factor in response to infection. Here we find that all of these 
genes are upregulated in dp120ctn mutant flies. A smaller subset (B, D) are 
further upregulated in response to heat shock in dp120 mutant flies. 
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3.3.13 Heterozygous loss of relish rescues aberrant gene expression 
in dp120ctn mutants. 
The DIRGs that I identified as aberrantly expressed in dp120ctn mutant flies are 
regulated by the relish NF-κB-like transcription factor (De Gregorio et al., 2001, 
De Gregorio et al., 2002). Interestingly, it has been described that p120ctn loss 
in the murine epidermis leads to constitutive activation of NF-κB (De Gregorio et 
al., 2001, De Gregorio et al., 2002, Perez-Moreno et al., 2006, Perez-Moreno et 
al., 2008). I wanted to test whether the divergent transcriptional profile I had 
observed in dp120ctn mutant flies was dependent on the NF-κB-like transcription 
factor relish. To do this I combined dp120ctn mutant flies with one copy of a 
null allele of relish (RelE20) to half the genetic dose of relish (w1118; p120308; 
RelE20/+). I extracted total RNA from control (w1118), dp120ctn mutant (w1118; 
p120308) and dp120ctn mutant females carrying either one copy of a null allele 
for relish (RelE20) (w1118; p120308; RelE20/+) or a transgene expressing dp120ctn-
GFP under the control of the ubiquitin promoter (w1118; p120308; ubi-p120-GFP) 
and measured levels of selected relish regulated DIRGs (AttD, PGRP-LB, PGRP-
SC2, PGRP-SD and Sp4) (Fig 3.17A-E) (De Gregorio et al., 2001, De Gregorio et 
al., 2002). In dp120ctn mutant flies (w1118; p120308) all targets were significantly 
unregulated with respect to control flies (w1118). As in the case of heat shock 
expression of dp120ctn-GFP rescued the expression levels of these key targets 
(Fig 3.17A-E). Most remarkably, halving the genetic dose of relish (w1118; p120308; 
RelE20/+) rescued the expression of these targets to levels similar to control flies 
(w1118).  This data further suggest that dp120ctn is required to negatively 
regulate relish dependent transcription in Drosophila.  
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Figure 3.17 Heterozygous loss of relish rescues aberrant gene expression in 
dp120ctn flies.  
(A-E) qPCR analysis of selected genes in w1118, w1118; p120ctn308, w1118; 
p120ctn308; ubi-p120ctn-GFP and w1118; p120ctn308; relE20/+ flies (one-way ANOVA 
with Bonferroni post test correction, ***p<0.001****p<0.0001).  The targets 
selected have been reported to be regulated by the relish transcription factor in 
response to infection. This aberrant expression is rescued by heterozygous loss 
of the transcription factor relish.  
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3.3.14 relish-RFP localization in dp120ctn mutants 
When the immune response is active, relish is cleaved and translocates to the 
nucleus where it drives transcription. In order to address whether relish was 
constitutively active in dp120ctn mutants I performed a preliminary experiment 
using an RFP tagged form of relish (Relish-RFP). We combined a UAS transgene 
for Relish-RFP with the daughterless Gal4  (dauG4) driver, that drives expression 
ubiquitously, in either a control (w1118; dauG4-Rel-RFP) or dp120ctn mutant 
background (w1118; p120308; dauG4-Rel-RFP).  I dissected intestines, which are 
known to be immune responsive, from control and dp120ctn mutant flies and 
looked at localization of Relish-RFP before and after 1 hour heat shock at 37°C 
(Fig 3.18).  Expression of the transgene was patchy in all the intestines analyzed 
suggesting that there was not ubiquitous expression using this driver (Fig 3.18). 
When we looked before heat shock we could observe that in control (w1118; 
dauG4-Rel-RFP) intestines Relish-RFP was diffuse in the cells (Fig 3.18A-A’’, 
white arrows). In dp120ctn mutant intestines (w1118; p120308; dauG4-Rel-RFP), 
Relish-RFP was more intense but no obvious nuclear localization was observed 
(Fig 3.18C-C’’, white arrows). After heat shock, there was clear nuclear 
accumulation in control intestines (Fig 3.18B-B’’, yellow arrows) and dp120ctn 
mutant intestines (Fig 3.18D-D’’, yellow arrows). However, the signal in 
dp120ctn mutant intestines was again more intense and I could observe clear 
membrane localization (Fig 3.18D-D’’, yellow arrows).  Although this was a 
preliminary experiment that will need to be repeated, it suggests that there may 
indeed be aberrant regulation of Relish in dp120ctn mutants.  
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Figure 3.18 Localization of Relish-RFP in d120ctn mutants. 
(A-D’’) Confocal images of 7 day old midguts from w1118; dauG4-Relish-RFP and 
w1118; p120308; dauG4-Relish-RFP flies before (A-A’’ and C-C’’) and after 1 hour 
Heat-shock (B-B’’ and D-D’’) stained with DAPI. White arrowheads in A-A’’ and 
C-C’’ highlight cytoplasmic localization of Relish-RFP. Yellow arrowheads in B-
B’’ and D-D’’ highlight nuclear localization of Relish-RFP after 1 hour HS. Scale 
bars 25µm. 
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3.3.15 Loss of dp120ctn enhances tumour burden in scribble and 
discs large mutant larvae 
As p120ctn has been described as potent tumour suppressor (Stairs et al., 2011) 
and is frequently downregulated or mislocalized in a variety of cancer types 
(Thoreson and Reynolds, 2002, Talvinen et al., 2010, Miao et al., 2010), I wanted 
to investigate how dp120ctn loss would affect tumour burden in an established 
model of cancer in Drosophila. To do this I utilized null mutants of two polarity 
tumour suppressors of the scribble (scrib) group, scribble and discs large. I first 
combined the null allele of dp120ctn (p120308) with a null allele for scrib (scrib1) 
to create double mutant larvae (p120308; scrib1). scrib larvae arrest at the larval 
stage due to transformation of the imaginal tissues. The larvae become giant 
and bloated (Fig 3.19A-A’). When I looked at dp120ctn-scrib mutant larvae I 
observed that they also arrested in the larval stage and looked to be even more 
bloated (Fig 3.19A-A’’). When I dissected wing imaginal disc tumours from these 
larvae and stained for DAPI, I could appreciate an increase in tumour size in 
dp120ctn-scrib larvae (Fig 3.19B-C). When I quantified tumour volume for 
tumours from scrib and dp120ctn-scrib larvae I found a significant increase in 
tumour burden (Fig 3.19D).  
  These results were encouraging but in order to consolidate them I 
decided to repeat the experiments with another null mutant for the polarity 
tumour suppressor discs large (dlg40.2) also part of the scrib group. As for scrib, I 
combined the dlg40.2 allele with the dp120ctn null allele to produce double 
mutant larvae (dlg40.2; p120308). Like scrib, dlg larvae arrest at the larval stage 
and become bloated as all imaginal tissues become transformed (Fig 3.19E-E’). 
Double mutant larvae also arrested at the larval stage and became even more 
bloated (Fig 3.19E-E’’). As with tumours dissected from dp120ctn-scrib double 
mutant larvae, tumours from dlg-dp120ctn larvae were larger than tumours from 
dlg larvae (Fig 3.19F-G). When I quantified this I found a significant increase in 
tumour burden in dlg-dp120ctn larvae (Fig 3.19H).  
 These results, although preliminary suggest that dp120ctn loss has a 
positive affect on tumour burden.   
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Figure 3.19 Loss of dp120ctn enhances tumour burden of scrib and dlg 
mutant larvae. 
(A-A’’ and E-E’’) Images of w1118 (5 day old), scrib1 (11 day old), p120308; scrib1 
(11 AED), dlg40.2 (11 AED) and dlg40.2; p120308 (11 day old) 3rd instar larvae. (B-C 
and F-G) Immunofluorescence of wing imaginal disc tumours from 11 AED scrib1, 
	   102 
p120308; scrib1, dlg40.2 and dlg40.2; p120308 3rd instar larvae stained for DAPI 
(dashed outlines mark tumour edges). (D, H) Quantification of Tumour Volume 
(D, p= 0.0093), (H, p= 0.0015).   
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3.3.16 Transcriptomic analysis of dp120ctn and scribble mutant 
tumours 
As I had preliminary evidence that dp120ctn could increase tumour burden (Fig 
3.19), I wanted to get an unbiased view of transcription in these tumours. I 
extracted total RNA of wing imaginal disc tumours from scrib (scrib1) and double 
mutant larvae (p120308; scrib1). Samples were purified and then sent to the 
MIAMI microarray facility at the Paterson Institute where the samples were 
hybridized to the Affymetrix GeneChip platform. After data collection the 
Beatson Institute Bioinformatics facility calculated fold change and significance. 
A cut off of 1.5/-1.5 in fold change and an adjusted p-value of 0.05 was used to 
select genes for analysis.  
  When I compared the transcriptional profile of these tumours (scrib1 vs 
p120308; scrib1) I found only around 200 genes were significantly up- or down 
regulated (Fig 3.20A-B). The Beatson Bioinformatics group performed a gene 
enrichment analysis on the data set but found no significant enrichment of any 
biological process or pathway. However, this may be due to our reduced data. 
For example, there are two genes that code for type VI collagen in Drosophila 
(Cg25C and Viking) and both these genes were significantly downregulated in 
wing disc tumours from double mutant larvae (p120308; scrib1). However, the 
gene enrichment analysis failed to detect this as significant despite 
downregulation of both family members. Additionally, we find several genes that 
are involved in purine biosynthesis (Fig 3.20B).  
 More analysis will be needed before we can understand how loss of 
dp120ctn is affecting tumour burden in Drosophila but taken together my data 
suggest that dp120ctn may also have tumour suppressor properties in Drosophila. 
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Figure 3.20 Transcriptomic analysis of dp120ctn - scribble tumours. 
(A) Graph displaying the numbers of genes up-or down regulated in each fold 
change category between scrib1 and p120308; scrib1 tumours. (B) Expression 
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profile (log2 expression values) of selected genes in biological replicates of 
scrib1 and p120308; scrib1 tumours.  
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3.4 Discussion 
3.4.1 dp120ctn in the stress response 
The generation of a dp120ctn null allele unambiguously demonstrated that 
dp120ctn was not required for Drosophila adhesion and development (Myster et 
al., 2003). dp120ctn mutant flies are viable and fertile but I hypothesized that 
as p120ctn is well conserved that it may be required in conditions of stress. I 
found this to be the case, as dp120ctn mutant flies  (w1118; p120308) were more 
sensitive to Heat shock at 37°C and displayed a reduced median lifespan (Fig 
3.4, 3.6 and 3.7). These phenotypes were rescued by ubiquitous overexpression 
of dp120ctn-GFP (Fig 3.8, 3.10 and 3.11), confirming that they were specific to 
loss of dp120ctn.  This is the first demonstration of a systemic requirement for 
dp120ctn in Drosophila.  
Heat shock stress is an acute stress stimulus while lifespan analysis 
measures the rate at which an organism becomes unable to deal with 
environmental stress over a protracted period of time. This suggested two 
hypotheses; either dp120ctn mutant flies  (w1118; p120308) are more sensitive to 
stress stimuli or they are inherently more stressed. In order to address this I 
looked at dp120ctn regulation under conditions of stress. dp120ctn-GFP localizes 
to the plasma membrane in the adult Drosophila posterior midgut (Fig 3.12 and 
3.13). In midguts, from heat-shocked flies, dp120ctn-GFP became specifically 
delocalized, diffuse and cytoplasmic while Arm (β-catenin) remained at the 
plasma membrane  (Fig 3.12 and 3.13). Immunoprecipitation and mass 
spectrometry analysis of dp120ctn-GFP demonstrated that a high molecular 
weight form of dp120ctn was stabilized upon heat shock (Fig 3.14). 
Unfortunately, from this analysis I was unable to ascertain if the two molecular 
weights corresponded to cleaved or phosphorylated substrates. In order to 
clarify and gain further insights I will repeat the immune precipitation and digest 
with a different protease in order to better understand the differences between 
the two isoforms I observed. Further analysis will also be needed to understand 
how dp120ctn is regulated under different conditions in Drosophila (Fig 3.21).  
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3.4.2 dp120ctn regulation of immune signalling 
The Imd signalling pathway is one arm of innate immune signalling in 
Drosophila (Kim and Kim, 2005). Its activation is highly controlled and then 
rapidly downregulated after infection to prevent a prolonged immune response 
(Kim and Kim, 2005). As such many negative regulators of the pathway have 
been identified (Bischoff et al., 2006, Zaidman-Remy et al., 2006, Kleino et al., 
2008). Using Microarray analysis I found that adult dp120ctn null flies aberrantly 
express several targets of the transcription factor relish before and after heat 
shock treatment (Fig 3.15 and 3.16).  Ubiquitous expression of dp120ctn-GFP or 
heterozygous loss of Relish rescued this aberrant expression (Fig 3.17). These 
results suggest that dp120ctn may play a role in the negative regulation of 
immune signalling in Drosophila. Preliminary experiments using an RFP labeled 
Relish (Relish-RFP) suggest that Relish localization maybe be disrupted in 
dp120ctn mutant flies (Fig 3.18, Fig 3.21).  
Together these data strongly support a role for dp120ctn in the negative 
regulation of the immune response as dp120ctn mutants express genes that are 
normally expressed during an immune response (Fig 3.15, 3.16 and 3.17). This is 
in accordance with evidence that loss of p120ctn in the murine epidermis, 
intestine, oral and esophageal tract results in acute inflammation in these 
tissues despite no barrier defects (Perez-Moreno et al., 2006, Smalley-Freed et 
al., 2010, Stairs et al., 2011, Smalley-Freed et al., 2011). These results propose 
a conserved role for dp120ctn in the regulation of immune signalling in 
Drosophila. 
To further consolidate these results I would like to address the functional 
contribution of relish to the dp120ctn mutant stress sensitive phenotype by 
examining whether reduction in the genetic dose of relish could rescue dp120ctn 
mutant stress sensitivity.  Moreover, I would like to address how dp120ctn might 
be regulating relish dependent transcription. This would be of great interest, as 
currently inflammation upon loss of p120ctn has been ascribed to epithelial 
barrier defects and recruitment of immune cells (Perez-Moreno et al., 2006, 
Perez-Moreno et al., 2008, Smalley-Freed et al., 2010, Smalley-Freed et al., 
2011). 
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3.4.3 dp120ctn and Cancer 
p120ctn down-regulation or delocalization in cancer correlates with poor 
prognosis (Vidal et al., 2010, Talvinen et al., 2010). Loss of p120ctn in the 
murine oral cavity and oesophagus results in Oral squamous cell cancers (OSCCs) 
and oesophageal squamous cell cancers (ESCCs) (Stairs et al., 2011). There is a 
growing body of evidence that p120ctn loss results in tumourigenesis through the 
establishment of an inflammatory microenvironment through the recruitment of 
immune cells (Perez-Moreno et al., 2006, Perez-Moreno et al., 2008, Stairs et 
al., 2011). Conditional knock down of p120ctn in the murine intestine and 
epidermis results in acute inflammation and immune cell infiltration (Perez-
Moreno et al., 2006, Perez-Moreno et al., 2008, Smalley-Freed et al., 2010, 
Smalley-Freed et al., 2011). Moreover, there are well established links between 
inflammation and tumourigenesis (Balkwill and Mantovani, 2001, Coussens and 
Werb, 2002, Hanahan and Weinberg, 2011).  
When I combined loss of dp120ctn with loss of two members of the 
scribble group of polarity tumour suppressors, scrib and dlg, I observed an 
increased tumour burden (Fig 3.19, Fig 3.21). Microarray analysis of tumours 
revealed a small set of genes that are differentially regulated in double mutant 
tumours (Fig 3.20). Gene enrichment analysis did not find enrichment of any 
particular pathways. However, several genes of interest were altered.  Of 
particular note is the down regulation of both type VI collagens (Cg25C and 
Viking) in scrib-p120ctn double mutant tumours, that have been shown to be 
important readout of cell invasiveness (Woodhouse et al., 1994) (Fig 3.20).  
As my analysis has so far focused on the tumour itself, I cannot discount 
that loss of dp120ctn did not result in an activation of immune signalling in other 
tissues such as the fat body, as I observed in adult dp120ctn mutants (Fig 3.15, 
3.16 and 3.17).  
In the future I would like to address how dp120ctn loss is cooperating with 
loss of scrib to increase tumour burden. I would like to quantify the level of 
proliferation and cell death in these tumours. I would also like to address if 
dp120ctn-scrib larvae have activated immune signalling as a result of dp120ctn 
loss. To do this I will extract RNA from fat bodies of tumour bearing larvae (TBL) 
and perform qPCR analysis for DIRGs (De Gregorio et al., 2001, De Gregorio et 
al., 2002). Additionally, I will also test the effects of dp120ctn knockdown 
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specifically in the tumour by combining RNAi for dp120ctn with the Ras-scrib 
model of oncogenic cooperation (eyRasV12; scrib1) (Brumby and Richardson, 2003, 
Pagliarini and Xu, 2003). Finally I would like to confirm the microarray hits by 
qPCR and assess the functional role of select genes in my model.  Future 
experiments will be focused on cultivating this line of research and further 
investigation of the role of dp120ctn in cancer.   
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Figure 3.21 dp120ctn mutants display a range of phenotypes. 
dp120ctn mutant flies display a reduced resistance to 37°C heat shock, a 
reduced lifespan and posses a unique transcriptional profile before and after 
heat shock which is relish dependent.  
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4 JAK/STAT and EGFR signalling are required for Apc1 
driven intestinal stem cell hyperplasia 
4.1 Summary 
Adenomatous polyposis coli (Apc) is a negative regulator of the Wnt signalling 
pathway, which is found frequently mutated in human colorectal cancer. Mouse 
models have demonstrated that constitutive activation of Wnt signalling upon 
loss of Apc leads to hyperproliferation of intestinal crypts and tumour formation.  
In this study, we have used the adult Drosophila midgut to uncover novel 
regulators of the Apc phenotype. We find a conserved role for dMyc and 
demonstrate the requirement of its transcriptional binding partner dMax upon 
Apc1 loss. We reduce hyperproliferation and extend survival of Apc1 null flies 
through downregulation of dMyc and dMax. Downstream we detect dMyc 
dependent upregulation of the upd2/3 cytokines and the Drosophila EGF spitz 
upon Apc1 loss. We establish a role for JAK/STAT signalling in the 
hyperproliferation of ISCs upon Apc1 loss that is mediated by dMyc dependent 
production of upd3 in ECs. Moreover we find a requirement for Drosophila EGFR 
DER within ECs for the upregulation of upd3 and proliferation of ISCs. Altogether 
our data describe novel mediators of the Apc phenotype in Drosophila and 
establishes the adult Drosophila midgut as a powerful model to study the 
molecular signalling underlying the Apc phenotype. 
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4.2 Introduction 
4.2.1 Wnt signalling 
The Wnt signalling pathways regulate many cellular processes including gene 
expression, cell adhesion and polarity. Wnt signalling can be divided into 
canonical and non-canonical and both pathways are activated through ligand 
receptor binding. Non-canonical Wnt signalling has been shown to regulate cell 
polarity, cell shape but does not require β-catenin. The work in this thesis 
relates to the canonical pathway and so I will only introduce this pathway. 
Canonical Wnt signalling is well conserved and plays essential roles in cell 
proliferation, differentiation and determination of cell fate (Seto and Bellen, 
2004, Cadigan and Peifer, 2009, Anastas and Moon, 2013) (Fig 4.1). Its 
misregulation can result in pathologies ranging from embryonic defects to 
tumourigenesis (Anastas and Moon, 2013). Through its effector β-catenin, Wnt 
signalling drives transcription of hundreds of genes (Seto and Bellen, 2004, White 
et al., 2007, Cadigan and Peifer, 2009, Anastas and Moon, 2013). Activation of 
Wnt signalling is achieved by binding of Wnts, a family of secreted glycoproteins, 
to the Frizzled (Fz) and LRP-5 receptors (Bhanot et al., 1996, Wehrli et al., 
2000). This leads to the stabilization and nuclear translocation of β-catenin that 
in cooperation with the transcription factor T cell factor (TCF) drives 
transcription of Wnt targets. When Wnts are not bound, β-catenin is targeted for 
degradation through the multi-component “destruction” complex (Clevers, 
2006). The complex includes Adenomatous polyposis coli (APC), Axin and two 
kinases, GSK3-β and CK1 which phosphorylate β-catenin targeting it for 
ubiquitination and subsequent proteasomal degradation (Seto and Bellen, 2004, 
Clevers, 2006, White et al., 2007, Anastas and Moon, 2013). This complex is 
inhibited by the dishevelled phosphoprotein that becomes phosphorylated when 
Wnt signalling is active (Clevers, 2006, White et al., 2007, Anastas and Moon, 
2013). Wnt target expression is actively repressed by binding of the 
transcriptional repressor Groucho together with TCF to DNA (Seto and Bellen, 
2004, Clevers, 2006, White et al., 2007, Anastas and Moon, 2013). This picture 
becomes more complex in mammalian systems due to the presence of several 
ligands and receptors. This is not surprising considering the many and diverse 
processes in which both, canonical and non-canonical Wnt signalling is involved 
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(Seto and Bellen, 2004, Clevers, 2006, White et al., 2007, Anastas and Moon, 
2013).  
 In Drosophila, canonical wingless (wg) signalling although simpler is highly 
homologous to canonical Wnt signalling in mammals (Seto and Bellen, 2004, 
Clevers, 2006, White et al., 2007, Anastas and Moon, 2013).  wg itself was first 
discovered in a screen for genes required for segment polarity in the embryo 
(Nusslein-Volhard and Wieschaus, 1980). wg signalling has been shown to be 
essential for cell differentiation and tissue patterning during Drosophila 
development (Cadigan and Nusse, 1997, Wodarz and Nusse, 1998).   
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Figure 4.1 Canonical WNT signalling 
Upon binding of WNTs to the Frizzled and LRP receptors, disheveled (Dvl) 
becomes phosphorylated and is able to suppress the formation of the destruction 
complex made up of APC, Axin, CK1 and GSK3-β allowing β-catenin to 
translocate to the nucleus and together with TCF drive gene expression. In the 
absence of WNTs, β-catenin is targeted for degradation through phosphorylation 
and consequent proteosomal degradation. Gene expression is actively repressed 
through Groucho and TCF. See text for more details.  
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4.2.2 The Mammalian small intestine 
The mammalian small intestine consists of an epithelial monolayer that carries 
out digestion and absorption of nutrients. In order to maximize surface area 
available for nutrient absorption, the epithelium of the small intestine is 
organized into proliferative crypts and small finger-like protrusions named villi 
(Radtke and Clevers, 2005). The intestinal epithelium is populated by 5 cell 
types: the intestinal stem cells (ISCs); the secretory lineage: the paneth cells, 
goblet cells and the enteroendocrine cells (ee); and the absorptive enterocytes 
(ECs) (Radtke and Clevers, 2005). The mammalian small intestine undergoes 
complete turn over once every 4-5 days. The ISCs, which are located at the base 
of each crypt, are marked by the expression of the Wnt target Lgr5 (Radtke and 
Clevers, 2005). Once a new cell is produced it will travel up the villus axis until 
it reaches the tip (Radtke and Clevers, 2005). Due to its rapid turnover and 
relatively simple architecture, the mammalian small intestine has been often 
used to investigate stem cell biology (Radtke and Clevers, 2005). 
 The Adult Drosophila midgut bears many similarities with the mammalian 
intestine (Casali and Batlle, 2009) and as described in detail in section 1.5 it is 
maintained by dedicated ISCs, which give rise to the differentiated secretory ee 
cells and absorptive ECs.   
 
4.2.3 Colorectal cancer 
In 2010, Colorectal cancer (CRC) diagnosis accounted for around 13% of all 
cancers diagnosed in the UK (CRUK.org). CRC is characterized by the presence of 
benign polyps that progress to malignant carcinomas. Around 80% of patients 
diagnosed with sporadic and inherited forms of CRC will have silencing mutations 
affecting the Apc gene (Kinzler et al., 1991, Kinzler and Vogelstein, 1996, 
Korinek et al., 1997). In the murine intestine, loss of Apc leads to acute 
activation of Wnt signalling and rapid tissue hyperplasia (Sansom et al., 2004) 
while targeted deletion of Apc in the ISCs leads to the expedited formation of 
discrete adenomas (Barker et al., 2009).  Constitutive activation of Wnt 
signalling results in the aberrant expression of many genes (Sansom et al., 2004, 
Holstege and Clevers, 2006, Sansom et al., 2007, Van der Flier et al., 2007). 
However, the relative contribution of these targets to the Apc phenotype and to 
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intestinal homeostasis needs to be addressed in order to develop novel and 
effective therapies for CRC. 
In the adult Drosophila midgut, as in the mammalian small intestine, loss 
of Apc from ISCs leads to hyperproliferation of the intestinal epithelium (Cordero 
et al., 2009, Lee et al., 2009). 
 
4.2.4  Aims of the project  
This project was conducted in collaboration with Dr Julia Cordero, a 
postdoctoral researcher working in the laboratory of Prof Owen Sansom. When I 
joined the lab Dr Cordero had recently published data demonstrating the affects 
of Apc downregulation in the adult Drosophila midgut (Cordero et al., 2009). 
Using this system she was able to demonstrate that Apc loss specifically in the 
ISCs led to a hyperproliferation of the ISCs (Cordero et al., 2009). Using this 
model we set out to uncover molecular mechanisms that underlie these 
phenotypes in the adult Drosophila midgut in order to gain insights into the 
mechanisms that mediate Human CRC. 
The work presented here is the product of a collaboration with Dr Cordero. 
Experiments were designed performed and analyzed together with Dr Cordero 
and this work has been included in a co-first author paper (Cordero et al., 
2012a). I also participated in work addressing the role of wg in homeostasis and 
regeneration in the Drosophila which was published in EMBOJ (Cordero et al., 
2012b). 
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4.3 Results 
4.3.1 Apc1 loss results in ISC hyperproliferation and reduced survival in the 
adult midgut 
Apc mutation in the murine intestine leads to complete disruption of tissue 
architecture and rapid morbidity (Sansom et al., 2004). In Drosophila, there are 
two Apc homologues, Apc1 and Apc2. During development these genes are 
redundant (Ahmed et al., 2002), but have been shown to have independent 
functions in the Drosophila male germ line (Yamashita et al., 2003). Knockdown 
of Apc1 within progenitor cells results in hyperproliferation of the adult 
Drosophila midgut (Cordero et al., 2009). We wanted to examine the effects of 
Apc1 loss on ISC proliferation. To do this we combined the null allele of Apc1 
(Apc1Q8) (Ahmed et al., 1998), with the ISC/EB Gal4 driver escargot-Gal4 driving 
UAS-GFP (esg>GFP) (Brand and Perrimon, 1993, Micchelli and Perrimon, 2006). 
Apc1 null flies are viable as Apc2 is able to take over Apc1 functions during 
development. When we compared the posterior midguts of Apc1 null 
heterozygotes (esg>GFP; Apc1Q8/+) (Ahmed et al., 1998), and homozygotes 
(esg>GFP; Apc1Q8) we found that midguts from Apc1 null homozygotes were 
hyperplastic and had increased numbers of ISCs/EBs as we observed an increased 
number of GFP+ve cells (Fig 4.1A and 4.1B). We measured proliferation in these 
midguts through staining with phosphohistone H3 (pH3+ve) antibody that marks 
all mitotic cells. We observed a significant increase in the number of pH3+ve cells 
(Fig 4.1C) confirming that Apc1 loss in the adult Drosophila midgut results in ISC 
hyperproliferation (Fig 4.2 A, B and C).  
In the mouse, conditional knockout of Apc leads to death of the animal in 
as quickly as 5 days (Sansom et al., 2004). We measured lifespan of flies carrying 
3 different Apc1 null alleles (Apc1Q8, Apc1x1 and Apc1S76) as homozygotes, trans-
heterozygotes and corresponding heterozygotes (Fig 4.2D).  In all combinations, 
Apc1 null flies displayed a significantly reduced lifespan when compared to their 
heterozygous controls (Fig 4.2D).  
In order to discount any developmental effects of Apc1 loss and confirm 
ISC proliferation upon Apc1 loss, we used the MARCM system to create GFP 
marked control (Lac-Z) and Apc1 null (Apc1Q8) clones (Lee and Luo, 2001). As we 
had observed in the midguts of Apc1 null flies, 14 day old Apc1 null clones 
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(Apc1Q8) had an increased number of cells per clone when compared to 
control clones (Lac-Z)  (Fig 4.2E, 4.2F and 4.2G).  
These results demonstrate that, as is the case in the mammalian intestine, Apc1 
loss in the adult Drosophila midgut results in a hyperplastic epithelium and Apc1 
loss is sufficient to induce ISC hyperproliferation in the adult Drosophila midgut. 
These phenotypes are consistent with what has been observed in the mammalian 
intestine and suggests a significant degree of conservation between these two 
tissues. Therefore the adult Drosophila midgut is a useful model to probe the 
molecular signature underlying the Apc phenotype. 
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Figure 4.2 Apc1 loss results in ISC hyperproliferation in the Drosophila 
midgut. 
(A-B) Immunofluorescence of 5 day old midguts from Apc1Q8/+ (A) and Apc1Q8 (B) 
flies with stained for GFP (Green) and DAPI (blue), Scale bar 20µm. (C) 
Quantification of the number of pH3+ve cells per posterior midgut. (D) Survival of 
Apc1 null allele homo and heterozygotes at 25°C (Log-rank tests, p values 
correspond to comparison between homo and trans-heterozygotes versus 
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appropriate heterozygotes) (E, F) Confocal images of 14 day old GFP MARCM 
clones stained for GFP (Green) and DAPI (blue). (G) Quantification of number of 
cells/clone (t-test ****p<0.0001).  
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4.3.2 dMyc is upregulated and required for the Apc1 phenotype in the 
adult Drosophila midgut. 
The Myc family of transcription factors regulate cell division, differentiation and 
apoptosis (Johnston et al., 1999, Trumpp et al., 2001). They are well defined 
proto-oncogenes and are frequently deregulated in many different cancers 
(Henriksson and Luscher, 1996). c-Myc has been shown to be required for the 
Apc phenotype in the murine intestine as its deletion completely suppressed 
tissue hyperplasia (Sansom et al., 2007, Athineos and Sansom, 2010).  
 In Drosophila, dMyc (diminutive-dm) is known to act downstream of wg in 
several contexts (Smith-Bolton et al., 2009). To further validate our model we 
wanted to test if dMyc would be required for the Apc1 phenotype in the adult 
Drosophila midgut. We first stained midguts from control (Apc1Q8/+) and Apc1 
null (Apc1Q8) flies with an antibody against dMyc (Fig 4.3A and 4.3B). dMyc levels 
were elevated in Apc1 null midguts suggesting that dMyc may be required in this 
context (Fig 4.3A and 4.3B).  To more directly access the role of dMyc in 
hyperplasia associated with Apc1 loss in the adult Drosophila midgut we created 
control (Lac-Z), Apc1 null (Apc1Q8) and Apc1 null (Apc1Q8) clones expressing RNA 
interference (RNAi) for either dMyc (myc-IR, Apc1Q8) or its transcriptional 
binding partner dMax (max-IR, Apc1Q8) (Steiger et al., 2008) (Fig 4.3C-G). We 
observed a significant decrease in the number of cells per clone in 14 day old 
dMyc knockdown (myc-IR, Apc1Q8) and dMax knockdown Apc1 null (max-IR, 
Apc1Q8) clones compared with Apc1 null only clones (Apc1Q8) (Fig 4.3H). This 
confirms that dMyc is required for hyperproliferation upon Apc1 loss in the adult 
Drosophila midgut. Moreover, it demonstrates the conservation of the Apc 
phenotype between the Drosophila and mouse intestine. 
 We next wanted to address if down-regulation of dMyc or dMax could 
revert an already established Apc1 phenotype, an experiment that is technically 
difficult to perform in the mouse. We combined RNAi for dMyc and dMax with a 
temperature sensitive Gal4 repressor, Gal80 (Gal80ts) fused to the promoter 
region of tubulin (tub-Gal80ts, UAS-myc-IR and tub-Gal80ts, UAS-max-IR, 
respectively) in order to control the expression of the RNAis using temperature. 
Using these tools we assayed the effect of dMyc and dMax knockdown in Apc1 
null clones and midguts of Apc1 null flies (Apc1Q8).   
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 For clones the experimental setup was as follows: clones for all 
genotypes were induced and allowed to grow at the non-permissive temperature 
(22°C) for 14 days (Fig 4.4A). Flies were then transferred to the permissive 
temperature (29°C) to allow de-repression of the Gal4 and therefore expression 
of the RNAis within the clones (Fig 4.4A). Midguts were dissected at different 
time points (Fig 4.4A, * denotes time points when flies were taken) and the 
number of cells per clone was quantified.  We observed no difference between 
Apc1 null (Apc1Q8) clones, dMyc knockdown (myc-IR, Apc1Q8) and dMax 
knockdown Apc1 null (max-IR, Apc1Q8) clones after one day at the permissive 
temperature (15 day) (Fig 4.4C, 4.4D and 4.4E).  However, both after 7 and 14 
days at the permissive temperature (21 and 28 days total respectively) we 
observed a significant decrease in clone size in both dMyc knockdown (myc-IR, 
Apc1Q8) and dMax knockdown Apc1 null (max-IR, Apc1Q8) clones (Fig 4.4C’, 4.4D’, 
4.4D’’, 4.4E’ and 4.4E’’).   
 We also combined these tools with Apc1 null flies (Apc1Q8) and the ISC/EB 
Gal4 driver escargot-Gal4 driving UAS-GFP (esg>GFP). This again allowed us to 
control when the RNAi was active and allowed us to downregulate dMyc and 
dMax specifically in the ISCs/EBs. As in the previous experiment, flies were kept 
at the non-permissive (22°C) for 5 days before being transferred to the 
permissive temperature (29°C) for a further 7 days (Fig 4.5A). Midguts were 
dissected at 5 and 7 days (Fig 4.5A, * denotes time points when flies were taken) 
and the number of pH3+ve cells was quantified (Fig 4.5B-G).  We observed 
significantly fewer pH3+ve cells in Apc1 null midguts expressing RNAi for dMyc and 
dMax in ISCs/EBs  (myc-IRts; Apc1Q8 and max-IRts;Apc1Q8) (Fig 4.5G).  
 Finally we wanted to examine if the suppression of Apc1 driven 
hyperplasia we observed could translate into increased survival. For this we 
measured the lifespan of Apc1 null flies expressing RNAi for either dMyc or dMax 
in the ISCs/EBs. Strikingly, we observed a significant increase in lifespan in Apc1 
null flies expressing RNAi interference for either dMyc or dMax when compared 
to Apc1 null flies (Fig 4.6A-B).  
These results demonstrate that dMyc and dMax are required for the Apc1 
phenotype in the adult Drosophila midgut and down-regulation of these genes 
suppresses and regresses hyperproliferation associated with Apc1 loss. 
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Figure 4.3 dMyc is required for Apc1 associated hyperplasia. 
(A-B) Immunofluorescence of 5 day old midguts from Apc1Q8/+ (A) and Apc1Q8 (B) 
flies with stained for dMyc (red) and DAPI (blue), Scale bar 20µm. (E, F) Confocal 
images of 14 day old GFP MARCM clones of the indicated genotypes stained for 
GFP (Green) and DAPI (blue). (H) Quantification of the number of cells per clone 
(one-way ANOVA with Bonferroni post test correction, ****p<0.0001, ns-non 
significant). 
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Figure 4.4 dMyc or dMax downregulation regresses Apc1 clones. 
(A) Schematic representation of experimental setup. (B-E’’) Confocal images of 
GFP MARCM clones of the indicated genotypes and ages stained for GFP (green) 
and DAPI (blue). (F) Quantification of the number of cells per clone (one-way 
ANOVA with Bonferroni post test correction, ****p<0.0001, ns-non significant). 
  
	   125 
 
Figure 4.5 dMyc or dMax downregulation in ISCs of Apc1 null midguts reverts 
Apc1 null midgut phenotype. 
(A) Schematic representation of experimental setup. (B-F) Immunofluorescence 
of midguts of the indicated genotypes and ages stained for pH3 (red) and DAPI 
(blue). (G) Quantification of the number of pH3+ve per posterior midgut (one-way 
ANOVA with Bonferroni post test correction, * p<0.05, ***p<0.001 and ns-non 
significant). 
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Figure 4.6 Survival of Apc1 null flies rescued by dMyc or dMax 
downregulation. 
(A-B) Lifespan analysis of Apc1 null flies (Apc1Q8) expressing RNAi for either dMyc 
(A) or dMax (B) under the control of esgGal4. p values generated using log-rank 
tests (p values correspond to comparison between Apc1Q8 homozygotes 
expressing RNAi for myc (A- Purple versus Green) or max (B- Red versus Blue).  
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4.3.3 Loss of Apc1 leads to JAK/STAT pathway activation  
Many studies have examined the contribution of different signalling pathways on 
the regulation of ISC proliferation in the adult Drosophila midgut (Beebe et al., 
2009, Buchon et al., 2009b, Jiang and Edgar, 2009, Jiang et al., 2009, Shaw et 
al., 2010, Ren et al., 2010, Karpowicz et al., 2010, Jiang and Edgar, 2011). We 
wanted to ascertain which if any of these pathways might also be required for 
the hyperproliferation of ISCs upon loss of Apc1.  
The highly conserved JAK/STAT signalling pathway has been shown to be 
required for homeostasis and proliferation of the ISCs in response to damage in 
the adult Drosophila midgut (Beebe et al., 2009, Buchon et al., 2009b, Jiang et 
al., 2009) and is an important mediator of hyperproliferation induced as a result 
of hyperactivation of EGFR and Hippo/Yorkie signalling (Jiang et al., 2009, Shaw 
et al., 2010, Ren et al., 2010, Karpowicz et al., 2010, Jiang and Edgar, 2011). In 
Drosophila, the pathway is activated when secreted cytokines known as upds 
(upd, upd2, upd3) bind the receptor domeless (dome). This leads to the 
phosphorylation of the receptor associated Janus Kinase – JAK, hopscotch (hop). 
Inactive monomers of Stat92E (signal transducer and activator of transcription-
STAT) are recruited and phosphorylated which results in the formation of active 
dimers. Stat92E dimers translocate the nucleus where they activate 
transcriptional targets of the JAK/STAT pathway (Arbouzova and Zeidler, 2006).   
Upds are known to be upregulated upon tissue damage. In order to 
understand if upds were upregulated in Apc1 (Apc1Q8) null midguts, we 
performed qPCR on total RNA from control (Canton-S) and Apc1 null (Apc1Q8) 
midguts for all three upds (upd, upd2, upd3) and for the negative regulator of 
JAK/STAT signalling socs36E, an established target of the pathway (Fig 4.7A). We 
detected a significant increase in expression of upd2, upd3 and socs36E but not 
upd in Apc1 null midguts suggesting a strong activation of JAK/STAT signalling 
upon loss of Apc (Fig 4.7A) 
We next combined the Apc1 null allele (Apc1Q8) with a lacZ reporter for 
upd3 expression (upd3-lacZ) (Jiang et al., 2009) to investigate the pattern of 
expression within the midgut (Fig 4.7B-D’). When we looked at control 
(Apc1Q8/+) midguts we rarely detected lacZ expression, this was in stark contrast 
to what we observed in Apc1 null (Apc1Q8) midguts, where lacZ expression could 
be detected throughout the midgut (Fig 4.7B-C). When we looked more closely 
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we detected lacZ only in the large absorptive ECs, marked by the lack of 
Delta and Prospero staining, which mark the ISC and ee cell respectively, (Fig 
4.7D-D’, white arrows).  We further confirmed JAK/STAT activation upon Apc1 
loss by using a reporter of JAK/STAT pathway activation, 10xStat-GFP (Bach et 
al., 2007). When we combined this reporter with the Apc1 null allele (Apc1Q8) we 
found that in midguts from Apc1 null (Apc1Q8) flies had increased STAT activation 
within ISCs whereas in control (Apc1Q8/+) midguts only a few ISCs were GFP 
positive (Fig 4.7E-F, white arrowheads). 
These results suggest that upon loss of Apc1, Upd3 is secreted by ECs 
activating JAK/STAT signalling in ISCs.  
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Figure 4.7 JAK/STAT signalling is activated upon Apc1 loss.  
(A) qPCR analysis for upd, upd2 and upd3 in control and Apc1Q8 midguts. (B-D’) 
Immunofluorescence of 5 day old midguts from Apc1Q8/+ (B) and Apc1Q8 (C-D’) 
flies carrying the upd3-lacZ reporter stained for Delta/Prospero to mark ISCs/ee 
(red-membrane/nuclear) and lacZ (green) – white arrowheads point to small 
delta and prospero positive cells not expressing upd3-lacZ. (E-F) 
Immunofluorescence of 5 day old midguts from Apc1Q8/+ (E) and Apc1Q8 (F) flies 
carrying the 10xSTAT-GFP reporter stained with Armadillo (red) and GFP (green) 
– white arrowheads point to small ISCs positive for GFP. Scale bars 50µm. 
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4.3.4 JAK/STAT signalling is functionally required for hyperproliferation 
upon Apc1 loss 
As we had now established that JAK/STAT signalling was activated downstream 
of Apc1 loss, we next wanted to address the functional relevance of JAK/STAT 
signalling for the hyperproliferation of ISCs in Apc1 midguts. Importantly, 
downregulation of STAT signalling does affect ISC proliferation but rather results 
in differentiation defects (Beebe et al., 2009, Jiang et al., 2009). We used the 
MARCM system to induce Apc1 null (Apc1Q8) clones, dome knockdown (dome-IR; 
Apc1Q8) and Stat92E knockdown Apc1 null clones (stat-IR; Apc1Q8) (Lee and Luo, 
2001). We quantified the number of cells per clone and the percentage number 
of clones with pH3+ve cells (Fig 4.8A-E). We observed a significant decrease in 
the size of dome knockdown (dome-IR; Apc1Q8) and Stat92E knockdown Apc1 null 
clones (stat-IR; Apc1Q8) (Fig 4.8A-D). Moreover, the percentage number of clones 
with pH3+ve cells was also reduced when JAK/STAT signalling was downregulated 
within Apc1 clones (Fig 4.8E).  
 These data clearly demonstrate that JAK/STAT signalling is essential for 
hyperproliferation of ISCs upon loss of Apc1 in the adult Drosophila midgut.  
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Figure 4.8 JAK/STAT signalling is required for ISC hyperproliferation upon 
Apc1 loss.  
(A-C) Confocal images of 14 day old GFP MARCM clones of the indicated 
genotypes and ages stained for GFP (Green) and DAPI (blue). (D) Quantification 
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of the number of cells per clone (one-way ANOVA with Bonferroni post test 
correction, ****p<0.0001). (E) Quantification of the percentage number of clones 
with pH3+ve cells.   
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4.3.5 Activation of JAK/STAT signalling and dMyc upregulation are both 
required for Apc1 associated hyperproliferation 
Loss of Apc1 leads to hyperproliferation of ISCs as a result of dMyc upregulation 
and the activation of JAK/STAT signalling.  We wanted to address whether these 
pathways were working in parallel or in epistasis to one another.  
To address this we examined if JAK/STAT activation upon Apc1 loss was 
dependent on the levels of dMyc. We performed qPCR analysis for levels of upd3 
and socs36E on control (Canton-S), Apc1 null (Apc1Q8) and dMyc knockdown Apc1 
null flies (esg>myc-IRts; Apc1Q8) (Fig 4.9A). We observed a significant reduction 
in upd3 and socs36E levels in dMyc knockdown Apc1 null midguts (esg>myc-IRts; 
Apc1Q8) (Fig 4.9A).  This suggested that dMyc upregulation was required for 
JAK/STAT activation upon Apc1 loss. If this were the case we would expect to 
see dMyc up-regulation even in the absence of JAK/STAT activation in Apc1 null 
midguts. We tested this hypothesis using the previously described (section 4.3.4) 
Apc1 null MARCM clones together knockdown for JAK/STAT signalling 
components dome and Stat92E. When we stained these midguts for dMyc we 
observed a significant decrease in dMyc upregulation in dome knockdown Apc1 
null clones compared to Apc1 (Apc1Q8) null clones (Fig 4.9B-C’). However, 
downregulation of Stat92E in Apc1 null clones did not significantly affect dMyc 
levels (Fig 4.9B-B’ and 4.9D-D’). This suggested the existence of a cross talk 
between these pathways rather than a direct epistatic relationship.  
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Figure 4.9 JAK/STAT signalling activation upon Apc1 loss requires dMyc. 
(A) qPCR analysis for upd3 and socs36E in control, Apc1Q8  and esg>myc-IRts; 
Apc1Q8 midguts. (B-D’) Immunofluorescence of 14 day old MARCM clones from 
Apc1Q8, dome-IR; Apc1Q8 and stat-IR; Apc1Q8 flies stained with GFP (green), dMyc 
(red/grey) and DAPI (blue). 
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4.3.6 EGFR signalling links dMyc and JAK/STAT signalling upon loss of 
Apc1 
When we examined the relationship between the levels of dMyc and JAK/STAT 
signalling we found that JAK/STAT activation was dependent on dMyc (Fig4.9A). 
However, we also found that downregulation of dome reduced dMyc levels 
(Fig4.9B-C’) while downregulation of Stat92E did not significantly affect dMyc 
levels (Fig 4.9B-B’ and 4.9D-D’).  Moreover, upd3 is produced by ECs upon Apc1 
loss (Fig 4.7) and JAK/STAT activation is absolutely required for ISC proliferation 
upon Apc1 loss (Fig 4.8). These results suggested a paracrine cross talk from ECs 
to ISCs upon loss of Apc1 which results in hyperproliferation.  
 It was previously shown that JAK/STAT signalling is activated by 
overexpression of the Drosophila EGF-like ligands and that EGF-R signalling can 
be activated through over expression of upds (Buchon et al., 2010, Jiang et al., 
2011, Biteau and Jasper, 2011). We hypothesized that EGFR signalling could be 
involved in this paracrine signalling and possibly link these two pathways. 
 We first examined whether EGF ligands were upregulated upon Apc1 loss 
in the adult Drosophila midgut. We performed qPCR analysis on midguts from 
control (Canton-S) and Apc1 null (Apc1Q8) flies for the EGF-like ligands vein, 
keren and spitz. We observed upregulation of vein and spitz upon Apc1 loss 
while keren levels were unchanged (Fig 4.10A). We repeated the analysis on 
Apc1 null flies also expressing RNAi for dMyc in ISCs/EBs  (esg>myc-IRts; Apc1Q8). 
We found a strong dMyc dependency of spitz expression in midguts upon Apc1 
loss (Fig 4.10A). These experiments suggested that spitz might be involved in the 
induction of upd3 downstream of dMyc upon Apc1 loss.  
 To test the functional requirement of spitz in ISCs upon Apc1 loss we 
combined RNAi for Apc1 (Apc1-IR) with RNAi for spitz (spitz-IR) specifically in 
ISCs/EBs using the esgGal4 driver (Fig 4.10B-E). We quantified the number of 
pH3+ve cells to measure proliferation of ISCs in these conditions. Knockdown of 
Apc1 (Apc1-IR) resulted in a significant increase in ISC proliferation while 
midguts expressing GFP (esg>GFP) alone and knockdown of spitz (esg>spitz-IR) 
had similar levels of proliferation.  In double knockdown midguts (esg>spitz-IR; 
Apc1-IR) we observed a significant decrease in ISC proliferation when compared 
to Apc1 knockdown alone (esg>Apc1-IR) (Fig 4.10F). Therefore, knockdown of 
spitz was able to suppress hyperproliferation of ISCs.  
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To test if EGFR signalling was required for the upregulation of upd3 in 
ECs we utilized a dominant negative form of Drosophila EGFR (DERDN) in 
combination with ectopic expression of wg (DERDN; wg) specifically in ECs using 
an enterocyte specific Gal4 driver (MyoIAtsGal4, myosin IA) (Jiang et al., 2009). 
Expression of wg (MyoIAts>wg) in the ECs led to hyperproliferation of ISCs and a 
significant increase in the number of pH3+ve cells (Fig 4.11B and 4.11E) while 
very few pH3+ve cells were observed in midguts expressing DERDN (MyoIAts>DERDN) 
or GFP (MyoIAts>GFP) alone (Fig 4.11A, C and 4.11E). In midguts were wg and 
DERDN were overexpressed together (MyoIAts>DERDN; wg) the increase in pH3+ve 
cells observed in wg overexpression midguts (MyoIAts>wg) was completely 
suppressed (Fig 4.11D and 4.11E). We next performed qPCR analysis for upd3 on 
MyoIAts >GFP, MyoIAts >wg and MyoIAts >DERDN; wg midguts. We observed an 
increase in upd3 expression upon wg overexpression that was suppressed when 
wg was overexpressed together with a dominant negative form of Drosophila 
EGFR (MyoIAts >DERDN; wg) (Fig 4.11F).  
These data demonstrate that EGFR signalling is required within the ECs 
for production of upd3 upon activation of wg signalling. 
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Figure 4.10 spitz is required within ISCs for hyperproliferation upon Apc1 
loss. 
(A) qPCR analysis for the EGF-like ligands vein, keren and spitz in control, Apc1Q8  
and esg>myc-IRts; Apc1Q8 midguts. (B-E) Immunofluorescence of 14 day old 
midguts from esg>GFP (B), esg>Apc1-IR (C), esg>spitz-IR (D) and esg> spitz-IR; 
Apc1-IR (E) flies stained with GFP (green), pH3 (red) and DAPI (blue). (F) 
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Quantifications of the number of pH3+ve cells per posterior midgut (one-way 
ANOVA with Bonferroni post test correction, ***p<0.001 and **p<0.01).  
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Figure 4.11 EGFR signalling is required within the ECs for ISC proliferation 
upon activation of wg signalling. 
(A-D) Immunofluorescence of 14 day old midguts from MyoIAts>GFP (A), 
MyoIAts>wg (B), MyoIAts>DERDN (C) and MyoIAts>DERDN; wg (D) flies stained for 
GFP (green), pH3 (red) and DAPI (blue). (E) Quantifications of the number of 
pH3+ve cell per posterior midgut (one-way ANOVA with Bonferroni post test 
correction, **p<0.01). (F) qPCR analysis for upd3 in MyoIAts>GFP, MyoIAts>DERDN 
and MyoIAts>DERDN; wg midguts. 
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4.4 Discussion 
4.4.1 dMyc and dMax are required for Apc1 driven hyperproliferation in the 
adult Drosophila midgut. 
Myc is an essential mediator of the Apc phenotype in the mammalian intestine 
(Sansom et al., 2007, Athineos and Sansom, 2010). This work demonstrates the 
conservation of this interaction in the adult Drosophila midgut. Moreover, 
knockdown of dMyc or its transcriptional binding partner dMax was able to 
regress Apc1 driven hyperplasia and extend survival of Apc1 mutant flies. These 
data reinforce the therapeutic potential of Myc/Max targeted therapies in CRC.  
 
4.4.2 JAK/STAT signalling is activated upon Apc1 loss and is required for 
hyperplasia of ISCs in the adult Drosophila midgut.  
Activation of JAK/STAT signalling is a common feature of CRC (Kusaba et al., 
2005). The role of JAK/STAT in the mammalian intestine is not completely 
understood. Stat3 is activated in adenomas from ApcMin/+ mice and deletion of 
Stat3 in this model retarded tumourigenesis but later resulted in the formation 
of invasive tumours and upregulation of other Stat family members (Musteanu et 
al., 2010). In the adult Drosophila intestine, JAK/STAT signalling has been shown 
to be fundamental for homeostasis and damage induced proliferation (Jiang et 
al., 2009). Upon damage ECs produce upds which activate JAK/STAT signalling 
within the ISCs (Jiang et al., 2009).  
 Using a model of Apc1 loss in the adult Drosophila midgut we have 
demonstrated a dMyc dependent activation of JAK/STAT signalling in ISCs and a 
fundamental requirement of JAK/STAT signalling for Apc1 driven hyperplasia. 
Moreover, we describe the production of upds by the ECs upon loss of Apc1. Our 
data establish JAK/STAT signalling as an important mediator of Apc1 driven 
hyperplasia (Fig 4.12).  
 
4.4.3 EGFR signalling is required to mediate the crosstalk between the wg 
and JAK/STAT signalling pathways. 
EGFR signalling is required for ISC proliferation in homeostasis and damaged 
induced regeneration in the adult Drosophila midgut (Jiang and Edgar, 2009, 
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Jiang et al., 2011, Biteau and Jasper, 2011). Increased EGFR signalling upon 
Apc loss has been reported in the mammalian intestine (Moran et al., 2004). We 
find a requirement for the Drosophila EGF-like spitz within ISCs for proliferation 
upon Apc1 loss. Moreover, the EGF receptor DER is required in ECs for the 
expression of upds upon Apc1 loss. How the activation of EGFR signalling within 
the ECs leads to the upregulation of upds is unclear as previous studies have 
reported that EGFR signalling activation, as measured by pMAPK, occurs solely 
within the ISCs (Buchon et al., 2010, Biteau and Jasper, 2011, Jiang et al., 
2011). One explanation for the data is that EGFR signalling in this context does 
not involve MAPK activation; this is possible as the MAPK/ERK route is only one 
of several pathways downstream of EGFR activation. We also cannot discount 
the possibility that other factors may mediate the upregulation of upds upon 
EGFR activation.  
Overall, these results present a novel signalling network that upon Apc1 loss 
drives hyperproliferation of ISCs (Fig 4.12). 
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Figure 4.12 Intestinal hyperproliferation upon Apc1 loss is mediated through 
crosstalk of the EGFR and JAK/STAT signalling pathways. 
Loss of Apc1 results in activation of MYC production of spitz in the ISCs and upd3 
in the ECs. This leads to activation of the EGFR and JAK/STAT signalling 
pathways driving hyperproliferation of the ISCs.  
 
 
 
 
 
 
 
 
 
	   143 
5 Activation of Toll signalling in the fat body and 
expression of Eiger/TNF in haemocytes of tumour 
bearing larvae restricts tumour growth via apoptosis 
5.1 Summary 
The systemic response of the body to a growing tumour is poorly understood. We 
show for the first time that the Drosophila fat body is able to respond to the 
presence of a growing tumour by activating Toll signalling and demonstrate the 
ability of Toll signalling to restrict tumour growth. We identify the Drosophila 
haemocytes as the source of Spätzle to activate Toll signalling in the fat body 
and Egr/TNFα to induce tumour cell death. Finally, we describe differential 
roles for tumour intrinsic versus haemocyte-derived Egr/TNFα.  We report the 
requirement of tumour intrinsic Egr/TNFα for haemocyte proliferation via 
Pvf/Pvr signalling and haemocyte derived Egr/TNFα for tumour cell death. These 
results demonstrate the ability of the innate immune response to control tumour 
burden.   
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5.2 Introduction 
5.2.1 Cancer related inflammation 
 The existence of a connection between chronic inflammation and 
tumourigenesis has been long proposed. In 1971, Burnet formulated the “cancer 
immunosurveillance hypothesis”. In this, he speculated that the immune system 
may be able to recognize arising tumour cells as “non-self” and eliminate them 
(Burnet, 1971). Cancer related inflammation is now an accepted hallmark of 
cancer and is appreciated as both a cause and a consequence of tumourigenesis. 
Cancer related inflammation is thought to contribute to tumour cell 
proliferation, angiogenesis and metastasis and can arise from extrinsic factors 
that establish a chronic inflammatory response and intrinsic factors such as the 
nature of genetic lesions present within a tumour, which can result in the 
upregulation of inflammatory signalling (Balkwill and Mantovani, 2001, Coussens 
and Werb, 2002, Balkwill and Coussens, 2004, Mantovani et al., 2008, Balkwill, 
2009, Balkwill and Joffroy, 2010, Balkwill and Mantovani, 2010, Hanahan and 
Weinberg, 2011). Studies examining the role of tumour related inflammation in 
cancer progression have established that inflammation can both promote and 
hinder a cancer progression. However, due to genetic redundancy and the 
complexity of cytokine and immune signalling in mammals many open questions 
remain.  
 
5.2.1.1 Tumour necrosis factor α 
Tumour necrosis factor (TNF; also named TNFα) was first isolated in the 1970’s 
from the serum of bacterially infected mice (Carswell et al., 1975). When TNF 
was administered to tumour bearing mice it induced rapid necrosis of the 
tumours and hence it was named TNF (Carswell et al., 1975). Since then, TNF 
has been shown to be a key inflammatory cytokine with many family members 
(Locksley et al., 2001). There are two receptors for TNF, TNFR1 and TNFR2. 
TNFR1 is more generally expressed while TNFR2 is mostly expressed within the 
hematopoietic lineage (Locksley et al., 2001).  Once activated TNF/TNFR 
signalling can induce cell death or the expression of inflammatory and survival 
factors (Balkwill and Mantovani, 2010, Balkwill and Mantovani, 2012). Thus, 
mammalian TNF/TNFR signalling can result in both cell death and cell survival. 
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It is now clear that TNF can act as both anti and pro tumour factor 
depending on the cellular and genetic context (Balkwill and Joffroy, 2010). TNF 
is often detected in biopsies of human tumours both within the tumour and the 
surrounding stroma. Moreover, TNF has been detected in plasma from patients 
with advanced cancer (Beissert et al., 1989, Naylor et al., 1990, Karayiannakis 
et al., 2001, Yoshida et al., 2002, Ferrajoli, 2002, Bozcuk et al., 2004). In fact, 
TNF knockout mice are actually more resistant to chemical carcinogenesis than 
wild type mice (Moore et al., 1999). These context dependent roles of TNF 
suggest that correctly harnessed in the right situation TNF may still be able to 
induce tumour cell death.  
 
5.2.2 Drosophila Eiger/TNF 
Eiger (eda-like cell death trigger, Egr) is the only homologue of the mammalian 
cytokine TNF in Drosophila (Moreno et al., 2002, Igaki et al., 2002). 
Overexpression of Egr leads to activation of JNK signalling and JNK dependent 
apoptosis (Moreno et al., 2002, Igaki et al., 2002). Egr mutant flies are viable 
and develop normally, but have been shown to be more sensitive to infection 
from extracellular pathogens suggesting a role for Egr in the Drosophila immune 
response (Schneider et al., 2007). Conversely, Egr secretion has been shown to 
be required for organismal death in response to salmonella infection (Brandt et 
al., 2004). This suggests that like its mammalian counterpart, Egr has roles in 
mounting an appropriate inflammatory response but can also contribute to the 
pathology of infection in Drosophila (Brandt et al., 2004, Schneider et al., 2007).   
In the context of cancer work from our laboratory has shown that Egr is required 
for elimination of clones of transformed cells through the induction of JNK 
dependent apoptosis and that Egr can have both anti and pro tumour effects 
depending on the genetic context (Cordero et al., 2010).  
 
5.2.3 Mammalian Toll-like receptor signalling in Cancer 
Mammalian Toll-like receptor signalling is strikingly similar to Drosophila Toll 
signalling (described in detail in 1.6.1). However, unlike in Drosophila, the 
family of mammalian Toll-like receptors (TLRs) are pattern recognition receptors 
(PRRs) that activate the TLR signalling cascade upon binding of conserved 
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molecular patterns of pathogenic origin which can be both self or non self 
(Takeda et al., 2003).  The mammalian family of TLRs contains 9 members that 
are expressed in different subcellular localizations. Activation of TLR signalling 
leads to the activation of several signalling pathways including the NF-κB and 
JNK pathways (Lee and Kim, 2007). Activation of these signalling pathways is 
required for TLR dependent regulation of innate and adaptive immune responses 
(Akira, 2003, Beutler et al., 2003). 
 TLRs have also been shown to be required within tissues for homeostasis 
and repair (Rakoff-Nahoum et al., 2004, Seki et al., 2005, Zhang and 
Schluesener, 2006, Larsen et al., 2007, Michelsen and Arditi, 2007). Activation of 
TLRs is also thought to have anti-cancer effects (Salaun et al., 2006, Sfondrini et 
al., 2006, Krieg, 2007). However, MYD88 knockout mice have been shown to 
have a reduced tumour burden when combined with heterozygous loss of Apc 
and chemical carcinogenesis in the skin, suggesting that TLR signalling can also 
positively modulate cancer progression (Rakoff-Nahoum and Medzhitov, 2007, 
Swann, 2008). Given that TLR signalling can have both positive and negative 
effects on cancer progression more research is needed to understand the 
molecular context in which TLR signalling activation could be used to kill 
tumours. 
 
5.2.4 Aims of the project 
This project was conducted in collaboration with Dr Federica Parisi, a 
postdoctoral researcher working in our laboratory. When I joined the laboratory 
in October 2009 my supervisor Dr Marcos Vidal was working on a project to 
delineate the role of Egr/TNF in a larval tumour model in Drosophila. I was able 
to contribute to this project and we demonstrated that Egr/TNF played context 
dependent roles that could both positively and negatively influence tumour 
progression (Cordero et al., 2010).  In this project Dr Parisi and I aimed to 
further characterize the interaction between tumours and the innate immune 
response in larval models of cancer in Drosophila.  
Experiments were designed, performed and analysed together with Dr Parisi 
and this work has been included in a co-first author paper with Dr Parisi.  
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5.3 Results 
5.3.1 Toll signalling is activated in the fat bodies of tumour bearing larvae 
The scribble (scrib) group of tumour suppressors, which includes the l(2)gl, discs 
large (dlg) and scrib genes, has been extensively characterized for its role in the 
establishment of apical basal polarity in epithelial cells (Bilder, 2004). 
Homozygous loss of function mutations of any of these genes is sufficient to 
disrupt epithelial architecture and leads to neoplastic transformation of the 
mitotic imaginal discs. For this reason they have been used extensively in the 
field of Drosophila cancer research (Potter et al., 2000, Brumby and Richardson, 
2005, Stefanatos and Vidal, 2011, Rudrapatna et al., 2012, Gonzalez, 2013).  
Cancer associated inflammation requires the activation of the innate 
immune system (Hanahan and Weinberg, 2011). Using this model we wanted to 
understand the relationship between the tumour and the immune system in 
Tumour bearing larvae (TBL). Previous work has demonstrated that the 
haemocytes, one branch of the Drosophila innate immune system, are recruited 
to imaginal disc neoplasia and have the ability to influence tumour biology 
(Cordero et al., 2010, Pastor-Pareja et al., 2008).  
The fat body is a key tissue in Drosophila innate immunity and is the site 
of AMP production upon pathogenic infection (Hoffmann, 1995, Lemaitre and 
Hoffmann, 2007). We hypothesized that the fat body may respond to the 
presence of a growing tumour. In order to characterise this response further we 
performed qPCR analysis for known readouts of signalling pathways which have 
been previously implicated in immunity (Hoffmann, 1995, Lemaitre et al., 1996, 
Pastor-Pareja et al., 2008, Lemaitre and Hoffmann, 2007, Hetru and Hoffmann, 
2009, Karpac et al., 2011). We collected fat bodies from control (w1118), scrib   
(scrib1) null mutant, and Ras-scrib (eyRasV12; scrib1) larvae. We included Ras-
scrib (eyRasV12; scrib1) larvae in our experiment to control for tissue autonomous 
effects of scrib loss, as they carry eye imaginal disc tumours created through the 
MARCM system meaning that the rest of the larval tissues are wild type in these 
animals. Therefore, we only considered pathways that were upregulated in fat 
bodies from both scrib and Ras-scrib larvae (Fig 5.1). 
The JAK/STAT signalling pathway has been shown to have important roles 
in the regulation of the immune response (Arbouzova and Zeidler, 2006). In 
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Drosophila, it is important for resistance to viral infection (Lemaitre and 
Hoffmann, 2007). JAK/STAT signalling was previously reported to be activated 
systemically in TBL (Pastor-Pareja et al., 2008). Although we did observe an 
upregulation of the negative regulator and target of the pathway socs36E in scrib 
fat bodies (scrib1) this upregulation was not mirrored in eyRasV12-scrib fat bodies 
(eyRasV12; scrib1) (Fig 5.1A). This suggests that upregulation of this pathway may 
be a tissue autonomous effect of scrib loss in the fat body (Fig 5.1A). Therefore 
the role of JAK/STAT signalling in this model was not investigated further. 
Many studies have addressed the cross talk between metabolism and 
Inflammation (Hotamisligil and Erbay, 2008). The Drosophila fat body is both a 
metabolically and immunologically active tissue and since Insulin/FOXO 
signalling has been shown to regulate the expression of AMPs in response to 
starvation in Drosophila we wanted to examine if this pathway was altered in fat 
bodies of TBL (Becker et al., 2010).  We observed an increase in levels of Insulin 
receptor (InR) in scrib (scrib1) fat bodies but again this was not mirrored in 
eyRasV12-scrib fat bodies (eyRasV12; scrib1) (Fig5.1A). We also examined levels of 
the FOXO target thor (homologous to mammalian 4E-BP1) but did not observe 
any significant change in expression in these samples indicating that 
Insulin/FOXO signalling was not deregulated in the fat bodies of TBL (Fig5.1A).  
Mammalian Toll signalling has been heavily implicated in cancer related 
inflammation (Rakoff-Nahoum and Medzhitov, 2009, Maruyama et al., 2011). In 
Drosophila, the Toll signalling pathway is activated in the fat body upon 
infection and drives expression of AMPs. These AMPs include Drosomycin (Drs), 
Defensin (Def) and Metchnikowin (Mtk) (Lemaitre et al., 1996, Lemaitre et al., 
1997, Lemaitre and Hoffmann, 2007). We found that all three AMPs were 
upregulated in fat bodies of TBL  (Fig5.1B, w1118 vs scrib1). Moreover, this 
upregulation was also present in fat bodies of eyRasV12-scrib larvae (eyRasV12; 
scrib1) (Fig5.1B). This indicated that the activation of Toll signalling in the fat 
body occurs as a response to the presence of tumours. 
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Figure 5.1 Toll signalling is activated in the fat body of tumour bearing 
larvae. 
(A-B) qPCR analysis from fat bodies dissected from w1118, scrib1 and eyRasV12; 
scrib larvae for the indicated targets. Note the upregulation of Drs (Drosomycin) 
and Def (Defensin) two Toll Antimicrobial peptides (AMPs). 
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5.3.2 Toll signalling is required within the fat body to restrain tumour 
growth. 
In order to address directly the functional relevance of Toll activation in the fat 
body of TBL, we combined a null allele of the scrib group polarity tumour 
suppressor discs large (dlg40.2), which also carries imaginal disc tumours, with 
the fat body specific Gal4 driver pumpless-Gal4 (ppl>) (dlg40.2; ppl>toll) (Bilder 
et al., 2000, Woods and Bryant, 1991, Zinke et al., 1999).  
We utilized this mutant, as dlg is located on the X-chromosome and this 
left the 2nd and 3rd chromosome free to be combined with transgenes that would 
allow us to genetically dissect the effects of Toll signalling in the fat body on 
tumour growth. 
We upregulated Toll activation in the fat body by expressing a UAS 
transgene for the Toll receptor (dlg40.2; ppl>toll) and we inhibited Toll activation 
by expressing an RNAi transgene for the Toll adaptor Myd88 (dlg40.2; ppl>Myd88-
IR) which is required downstream of Toll receptor binding for Toll activation. We 
expressed a GFP transgene as a control. 
At 11 days after egg deposition (AED) we dissected wild type wing discs 
(w1118) and wing imaginal disc tumours from control (dlg40.2; ppl>GFP), Myd88 
knockdown (dlg40.2; ppl>Myd88-IR) and Toll overexpressing larvae (dlg40.2; 
ppl>Toll) and measured their volume (Fig 5.2). Wild type (w1118) wing imaginal 
discs are highly folded structures while wing imaginal disc tumours had a more 
rounded morphology and the folds are completely lost (Fig 5.2A-D). We found 
that tumours from larvae with impaired Toll activation were significantly bigger 
than those from control larvae (dlg40.2; ppl>GFP) (Fig 5.2B-E). In contrast, 
upregulated Toll activation achieved by overexpression of the Toll receptor 
(dlg40.2; ppl>Toll) resulted in a significant decrease in tumour volume (Fig 5.2B, 
5.2D and 5.2E). 
Taken together, these data indicate that activating Toll signalling in the 
fat body of TBL restricts tumour growth. 
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Figure 5.2 Toll signalling is required within the fat body to restrain tumour 
growth. 
(A-D) Immunofluorescence of a wild type wing imaginal disc (outlined with 
dashed white line) (A) and wing imaginal disc tumours from dlg40.2; ppl larvae 
expressing GFP (B), Myd88-IR (C) and Toll (D) in the fat body stained for Actin 
(outlined with dashed white line). Scale bars 100µm. (E) Quantification of 
tumour volume of tumours dissected from dlg40.2; ppl larvae expressing GFP, 
Myd88-IR and Toll in the fat body (one-way ANOVA with Bonferroni post-test 
correction, * p<0.05, ***p<0.001). 
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5.3.3 Spätzle is required within the haemocytes for activation of Toll 
signalling in the fat body. 
The Drosophila haemocytes are required for activation of Toll signalling in the 
fat body during infection through the production of the Toll receptor ligand 
Spätzle (spz) (Shia et al., 2009)(see section 1.6.1).  
To clarify whether spz is required for Toll activation in the fat body of 
TBL we tested the requirement of spz within the haemocytes of TBL. We used a 
haemocyte specific Gal4, hemolectin-Gal4 (hml>) (Goto et al., 2001) together 
with an RNAi transgene for spz (spz-IR) to specifically downregulate spz within 
the haemocytes (dlg40.2; hml> spz-IR). We also expressed a GFP transgene as a 
control (dlg40.2; hml> GFP).    
As previously, we dissected tumours from 11 AED control (dlg40.2; 
hml>GFP) and Spz knockdown (dlg40.2; hml>spz-IR) and measured their volume. 
Haemocyte-specific knockdown of spz  (dlg40.2; hml>spz-IR) resulted in a 
significant increase in tumour volume compared to tumours dissected from 
control larvae (dlg40.2; hml>GFP)  (Fig 5.3A-C). Additionally when we performed 
qPCR analysis on fat bodies from control (dlg40.2; hml>GFP) and Spz knockdown 
larvae (dlg40.2; hml>spz-IR) we observed a significant decrease in Drosomycin 
expression demonstrating a decrease in Toll activation. These results indicate 
that tumour-driven activation of Toll signalling in the fat body is mediated by 
the haemocytes via Spätzle secretion. 
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Figure 5.3 Spätzle is required within the haemocytes for activation of Toll 
signalling in the fat body. 
(A-B) Immunofluorescence of wing imaginal disc tumours from dlg40.2; hml larvae 
expressing GFP (A) and spz-IR (B) in the haemocytes stained for Actin (outlined 
with dashed white line). Scale bars 100µm. (C) Quantification of tumour volume 
of tumours dissected from dlg40.2; hml larvae expressing GFP and spz-IR in the 
fat body (t-test spz-IR *** p=0.0005). (D) qPCR analysis for Drosomycin in fat 
bodies from dlg40.2; hml larvae expressing GFP and spz-IR  in the haemocytes (t-
test spz-IR * p=0.0112). 
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5.3.4 Toll activation in the fat body of TBL restricts tumour growth 
through tumour cell death  
As we had established that Toll activation in the fat body of TBL was negatively 
affecting tumour size, we hypothesized that this may a result of increased cell 
death.  
To examine cell death in these tumours, we dissected wing imaginal discs 
from 5 AED wild type (w1118) larvae and tumours from 11 AED control (dlg40.2; 
ppl>GFP), Myd88 knockdown (dlg40.2; ppl>Myd88-IR) and Toll overexpressing 
(dlg40.2; ppl>Toll) larvae and stained them for cleaved caspase 3 (CC3) as a read 
out of apoptotic cell death (Fig 5.4). Wild type (w1118) imaginal discs displayed 
low or undetectable levels of apoptotic cell death (Fig 5.4A-A’) while tumours 
from control (dlg40.2; ppl>GFP) and Toll overexpressing larvae (dlg40.2; ppl>Toll) 
were regionally positive for CC3 (Fig 5.4B and 5.4D). In tumours from Myd88 
knockdown larvae (dlg40.2; ppl>Myd88-IR) CC3 positivity was similar to wild type 
wing discs (w1118) (Fig 5.4A-A’ and 5.4C-C’).  
In order to quantify CC3 in these tumours I developed a protocol using the 
Volocity 3D imaging analysis package (described in 2.3.1.4).  Using this protocol 
we were able to express % tumour cell death (Volume of CC3 positivity versus 
the total tumour volume) of wing imaginal disc tumours.  When we quantified 
the % Tumour cell death in tumours from control (dlg40.2; ppl>GFP), Myd88 
knockdown (dlg40.2; ppl>Myd88-IR) and Toll overexpressing (dlg40.2; ppl>Toll) 
larvae, we observed a significant decrease in % tumour cell death in tumours 
from Myd88 knockdown (dlg40.2; ppl>Myd88-IR), while tumours from Toll 
overexpressing (dlg40.2; ppl>Toll) larvae had a significant increase in % tumour 
cell death when compared to tumours from control (dlg40.2; ppl>GFP) larvae (Fig 
5.4F).  
As we had shown a requirement for haemocyte derived Spz for Toll 
activation we wanted to confirm that tumours from Spz knockdown (dlg40.2; 
hml>spz-IR) larvae phenocopied tumours from Myd88 knockdown (dlg40.2; 
ppl>Myd88-IR) larvae. We dissected tumours from 11 AED control (dlg40.2; 
hml>GFP) and Spz knockdown (dlg40.2; hml>spz-IR) larvae and stained for CC3. As 
we had observed in tumours from Myd88 knockdown (dlg40.2; ppl>Myd88-IR) 
larvae CC3 positivity was similar to wild type wing discs (Fig 5.4A-A’, 5.4D-D’ 
and 5.4E-E’). When we measured  % tumour cell death we observed a significant 
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decrease in % tumour cell death in tumours from Spz knockdown (dlg40.2; 
ppl>spz-IR) larvae. Thus, these data demonstrate the requirement of Toll 
signalling in the control of tumour burden through the induction of tumour cell 
death.  
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Figure 5.4 Toll activation in the fat body of TBL restricts tumour growth 
through tumour cell death. 
(A-E’) Immunofluorescence of a wild type (w1118) wing imaginal disc (A), tumours 
from dlg40.2; ppl larvae expressing GFP (B, B’), Myd88-IR (C, C’) and Toll (D, D’) 
and tumours from dlg40.2; hml larvae expressing spz-IR (E, E’) stained for actin 
and anti–cleaved caspase 3 (CC3) (outlined with dashed white line). Scale bars 
100µm. (F) Quantification of % Tumour cell death in tumours from dlg40.2; ppl 
larvae expressing GFP (B, B’), Myd88-IR (C, C’) and Toll (D, D’) (one-way ANOVA 
with Bonferroni post-test correction, * p<0.05, **p<0.005). (G) Quantification of 
% Tumour cell death in tumours from dlg40.2; hml larvae expressing GFP and spz-
IR (t-test **p=0.0013) 
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5.3.5 Egr/TNF is required in the haemocytes to execute Toll dependent 
tumour cell death  
We next wanted to address how tumour cell death was being executed 
downstream of Toll activation. Eiger/TNF (Egr/TNF) is a potent inducer of cell 
death and previous work from our laboratory has demonstrated that systemic 
loss of Egr/TNF was able to ameliorate some of the hallmarks of scrib mutants 
and that haemocytes recruited to tumours produced Egr/TNF (Cordero et al., 
2010). Moreover, Egr/TNF  depletion specifically in the haemocytes using RNAi 
prevented the death of lgl mutant clones, suggesting a role for Egr/TNF in the 
removal of transformed cells (Cordero et al., 2010). It has also been shown that 
TBL have an increased number of haemocytes and that reducing their number 
through expression of the pro-death protein Hid leads to an increase in tumour 
volume. We hypothesized that Egr/TNF may be playing a role in the execution of 
tumour cell death downstream of Toll. 
In order to address directly the role of haemocyte-derived Egr/TNF on 
tumour burden, we knocked down or overexpressed Egr/TNF specifically in 
haemocytes of TBL. We dissected tumours from 11 AED control (dlg40.2; 
hml>GFP), Egr/TNF  knockdown (dlg40.2; hml>egr-IR) and Egr/TNF  overexpressing 
(dlg40.2; hml>egr) larvae and measured tumour volume and % tumour cell death 
(Fig 5.4). We found that tumours dissected from haemocyte Egr/TNF knockdown 
(dlg40.2; hml>egr-IR) larvae had a significantly larger tumour volume than 
tumours from control (dlg40.2; hml>GFP) larvae (Fig 5.5A-D). Moreover, % tumour 
cell death was almost completely suppressed in Egr/TNF  knockdown (dlg40.2; 
hml>egr-IR) larvae when compared to control (dlg40.2; hml>GFP) larvae (Fig 
5.5E). Conversely, tumours from Egr/TNF  overexpressing (dlg40.2; hml>egr) 
larvae had a significantly reduced tumour volume and a significant increase in % 
tumour cell death (Fig 5.5A-E). Together these results indicate that haemocyte-
derived Egr/TNF is required for tumour cell death in TBL.  
Egr/TNF protein has been observed as intracellular puncta within tumour 
cells and at the plasma membrane of tumour-associated haemocytes (TAHs) 
(Igaki et al., 2009, Cordero et al., 2010). To visualise haemocyte-derived 
Egr/TNF in our system we expressed a venus-tagged form of Egr/TNF specifically 
in the haemocytes of tumour-free animals (he>egrvenus) or TBL (dlg40.2; 
he>egrvenus) using the haemocyte specific Gal4 driver hemese-Gal4 (he>) (Kurucz 
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et al., 2003) (Fig 5.6). We readily observed egrvenus expressing haemocytes 
associated to both control wing imaginal discs (he>egrvenus) from tumour-free 
larvae and to wing imaginal disc tumours (Fig 5.6). In control wing imaginal discs 
(he>egrvenus) Egrvenus was confined within the associated haemocytes, however in 
TBL, Egrvenus was detected in both associated haemocytes and within the tumour 
itself (Fig 5.6 compare A’’ with B’’, white and yellow arrowheads). These results 
suggest that haemocytes secrete Egr/TNF when associated with transformed 
tissues in order to induce apoptosis.   
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Figure 5.5 Egr/TNF is required in the haemocytes to execute Toll dependent 
tumour cell death. 
(A-C’) Immunofluorescence of tumours from dlg40.2; hml larvae expressing either 
GFP (A, A’), egr-IR (B, B’) or egr (C, C’) stained for Actin and anti–cleaved 
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caspase 3 (CC3) (outlined with dashed white line). Scale bars 100µm. (F) 
Quantification of tumour volume of tumours from dlg40.2; hml larvae expressing 
GFP, egr-IR or egr (E) Quantification of % tumour cell death in tumours from 
dlg40.2; hml larvae expressing GFP, egr-IR or egr (one-way ANOVA with 
Bonferroni post test correction, *p<0.05, **p<0.005, ***p<0.001, ****p<0.0001).  
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Figure 5.6 Egr/TNFα  is deposited by tumour associated haemocytes. 
(A-B’’) Confocal images of a wing imaginal disc from a he>egrvenus larva (A-A’’) 
and a tumour from a dlg40.2; he>egrvenus larva (B-B’’). Scale bars are 100µm and 
50µm respectively. White and yellow arrows highlight egrvenus expressing TAHs 
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5.3.6 Egr/TNF is required in the haemocytes downstream of Toll 
activation in the fat body to induce tumour cell death  
Given that we observed a correlation between Toll signalling activation in the 
fat body and tumour cell death, we next wanted to understand whether a 
haemocyte source of Egr/TNF was required to execute tumour cell death 
downstream of Toll activation. 
To address the relationship between Toll and Egr/TNF signalling in TBL, we used 
the cg-Gal4 driver (Asha et al., 2003), which drives expression in both the 
haemocytes and fat body in Drosophila, to enhance Toll activation and 
simultaneously knock down Egr/TNF in both the haemocytes and fat body. We 
dissected tumours from larvae expressing GFP (dlg40.2; cg>GFP)  , overexpressing 
Toll (dlg40.2; cg>Toll) and larvae overexpressing Toll and RNAi for Egr/TNF  
(dlg40.2; cg>Toll, egr-IR) under the control of cg-Gal4.  We found that tumours 
from larvae overexpressing both Toll and RNAi for Egr/TNF (dlg40.2; cg>Toll, egr-
IR) had a significantly larger tumour volume when compared to tumours from 
larvae expressing GFP (dlg40.2; cg>GFP) and overexpressing Toll alone (dlg40.2; 
cg>Toll)  (Fig 5.7A-D). Moreover, there was a significant decrease in % Tumour 
cell death in tumours from larvae overexpressing both Toll and RNAi for Egr/TNF 
(dlg40.2; cg>Toll, egr-IR) when compared to tumours from larvae expressing GFP 
(dlg40.2; cg>GFP) or overexpressing Toll alone (dlg40.2; cg>Toll) (Fig 5.7E). As we 
were using two transgenes by overexpressing both Toll and RNAi for Egr/TNF and 
only one copy of Gal4 we performed qPCR analysis on fat bodies from control 
(dlg40.2; cg>GFP), Toll overexpressing (dlg40.2; cg>Toll) and Toll overexpression - 
Egr/TNF knockdown (dlg40.2; cg>Toll, egr-IR)  larvae for Drosomycin. We 
performed this analysis to ensure that the observed increase in tumour volume 
and decrease in % tumour cell death was not a result of Gal4 titration. 
Drosomycin levels were equally increased in fat bodies from both Toll 
overexpressing (dlg40.2; cg>Toll) and Toll overexpression- Egr/TNFα knockdown 
larvae (dlg40.2; cg>Toll, egr-IR) when compared with fat bodies from control 
larvae (dlg40.2; cg>GFP) (Fig 5.7F).  
Additionally, we wanted to examine if Egr/TNFα knockdown (dlg40.2; 
cg>egr-IR) or Egr/TNFα overexpression (dlg40.2; cg>egr) in both the haemocytes 
and fat body affected the level of Toll activation. We performed qPCR analysis 
for Drosomycin on fat bodies from control (dlg40.2; cg>GFP), Egr/TNF knockdown 
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(dlg40.2; cg>egr-IR) and Egr/TNF overexpression (dlg40.2; cg>egr) larvae (Fig 
5.7G). We did not observe any effect on levels of Drosomycin in fat bodies from 
Egr/TNF knockdown (dlg40.2; cg>egr-IR) or Egr/TNF overexpression (dlg40.2; 
cg>egr) larvae when compared to levels in fat bodies from control larvae (dlg40.2; 
cg>GFP). These data suggesting Egr/TNF is required to induce tumour cell death 
downstream of Toll activation in the fat body but is not required in the 
haemocytes or fat body to modulate Toll activation. 
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Figure 5.7 Egr/TNF is required in the haemocytes downstream of Toll 
activation in the fat body to induce tumour cell death. 
(A-C’) Immunofluorescence of tumours from dlg40.2; cg larvae expressing GFP (A, 
A’) Toll (B, B’) or Toll, egr-IR (C, C’) stained for Actin and anti–cleaved caspase 
3 (CC3) (outlined with dashed white line). Scale bars 100µm. (D) Quantification 
of Tumour volume of tumours from dlg40.2; cg larvae expressing either Toll or 
Toll, egr-IR (one-way ANOVA with Bonferroni post-test correction, **p<0.01, 
****p<0.0001). (E) Quantification of % Tumour cell death in tumours from dlg40.2; 
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cg larvae expressing either Toll or Toll, egr-IR (one-way ANOVA with 
Bonferroni post-test correction, ***p<0.001, ns-no significance) (F) qPCR analysis 
of fat bodies from dlg40.2; cg larvae expressing either Toll (A, A’) or Toll, egr-IR 
for Drosomycin (one-way ANOVA with Bonferroni post test correction, ns-no 
significance *p<0.05). (G) qPCR analysis of fat bodies from dlg40.2; cg larvae 
expressing either GFP, egr-IR or egr for Drosomycin (one-way ANOVA with 
Bonferroni post-test correction, ns-no significance). 
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5.3.7 Egr/TNF is required within transformed cells to activate Toll 
signalling in the fat body. 
Depletion of Egr/TNF from the haemocytes or inhibition of Toll activation in the 
fat body of TBL results in an increased tumours burden as a consequence of 
decreased tumours cell death. These observations suggest that the relationship 
between these two pathways is important for a systemic immunosuppressive 
response.   
To examine the relationship between Egr/TNF and Toll signalling further 
and to test whether Egr/TNF was required for activation of Toll signalling, we 
combined a reporter for Toll signalling, Drosomycin-GFP (drs-GFP), with larvae 
mutant for scrib (scrib1) and larvae mutant for scrib and egr (egr3; scrib1). drs-
GFP reporter activation was observed in the fat body of scrib mutant larvae 
(scrib1) but not in double mutant egr-scrib larvae (egr3; scrib1) (Fig 5.8A-B). This 
suggests that Egr/TNF is required for Toll activation in the fat body of TBL. As 
we had excluded a role for Egr/TNF in both the fat body and haemocytes for Toll 
activation in TBL, we next considered whether tumour-intrinsic expression of 
Egr/TNF (Igaki et al., 2009) could mediate the activation of Toll signalling in the 
fat body.  
To test this possibility we induced the formation of wing imaginal disc 
dysplasia by driving RNAi for dlg (dlg-IR) under the control of scalloped-Gal4 
(sd>dlg-IR), which drives expression specifically in the wing pouch, in larvae 
carrying the drs-GFP reporter. We observed activation of Toll signalling in the 
fat body of sd>dlg-IR larvae (Fig 5.8C-C’). We repeated this experiment but 
combined RNAi for dlg with RNAi for Egr/TNF (sd>dlg-IR; egr-IR). Using this 
system we could knockdown Egr/TNF specifically within dlg transformed cells. 
We did not observe activation of Toll signalling in these larvae (Fig 5.8D-D’). 
These results suggest that Egr/TNFα is required within transformed cells for 
activation of Toll signalling in the fat body.  
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Figure 5.8 Egr/TNF is required within transformed cells to activate Toll 
signalling in the fat body 
(A-B) Fluorescent light microscopy images of scrib1 and egr3; scrib1 3rd instar 
larvae expressing the Toll reporter drosomycin-GFP (drs-GFP). (C-D’) Fluorescent 
light microscopy images of 3rd instar larvae (C’, D’) and immunofluorescence of 
fat bodies (C’, D’) from larvae expressing the Toll reporter drosomycin-GFP (drs-
GFP) and either dlg-IR or dlg-IR; egr-IR under the control of sd-Gal4. Scale bars 
1mm. (E-H’) Immunofluorescence a wild type (w1118) wing disc and tumours 
from dlg40.2, dlg40.2; egr3/1 and dlg40.2; hml>egr-IR stained for MMP1 and DAPI 
(outlined with dashed white line). Scale bars 100µm.  
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5.3.8 Egr/TNF is required within transformed cells for expression of 
MMP1  
Our results indicate that different sources of Egr/TNF  play distinct roles in TBL. 
Tumour-intrinsic Egr/TNF  is required to activate Toll signalling in the fat body 
while haemocyte-derived Egr/TNF is required to execute the tumour cell death 
program. Since disruption of the basement membrane has been reported to 
trigger haemocyte recruitment (Pastor-Pareja et al., 2008), we hypothesized 
that tumour intrinsic Egr/TNF  might be required for the expression of matrix 
metalloproteinase 1 (Mmp1) which is known to promote the degradation of the 
basement membrane (Cordero et al., 2010, Pastor-Pareja et al., 2008). To 
address this we dissected wild type (w1118) wing imaginal discs and tumours from 
dlg mutant (dlg40.2), dlg-egr mutant larvae (dlg40.2; egr3/1) and dlg mutant larvae 
expressing RNAi for Egr/TNF  specifically in the haemocytes (dlg40.2;hml>egr-IR) 
and stained for MMP1.  In wild type imaginal discs, we only observed MMP1 
staining in associated trachea (Fig 5.8E-E’, * marks associated trachea). Tumours 
from dlg mutant and dlg mutant larvae expressing RNAi for Egr/TNF specifically 
in the haemocytes, stained strongly for MMP1 (Fig 5.8F-F’ and 5.8H-H’) while 
tumours from dlg-egr mutant larvae (dlg40.2; egr3/1) were only positive for MMP1 
in the associated trachea (Fig 5.8G-G’). These data demonstrate a requirement 
for tumour-intrinsic Egr/TNF for MMP1 expression in transformed epithelia.  
Together these results point to a correlation between Egr/JNK signalling 
in the tumour and Toll activation in the fat body, as systemic loss of 
Egr/TNF  prevents Toll activation in response to tumour burden and MMP1 
production within the tumour. The haemocytes could link these two tissues as 
we have demonstrated a requirement for haemocyte derived Spätzle for Toll 
activation in the fat body and it has been shown that numbers of haemocytes 
increase in the presence of a tumour (Pastor-Pareja et al., 2008). Thus, we 
wanted to test whether Egr/TNF expression within the tumour affected 
haemocyte proliferation. We hypothesized that a higher number of haemocytes 
could enhance Toll signalling activation in the fat body through the increased 
production of Spätzle. 
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5.3.9 Pvr signalling is required for increased haemocyte numbers to 
restrict tumour burden.  
Drosophila Pvfs are homologous to vertebrate VEGF/PDGF and have been shown 
to drive haemocyte migration and proliferation in different contexts (Munier et 
al., 2002, Wood et al., 2006, Parisi and Vidal, 2011). Mammalian VEGF and PDGF 
play important roles in both wound healing and tumourigenesis as they are 
required for angiogenesis and inflammatory infiltrate recruitment (Arwert et al., 
2012). 
In order to test if Pvfs were responsible for the increased number of 
haemocytes in TBL, we performed qPCR analysis on wild type (w1118) wing 
imaginal discs as well as wing imaginal disc tumours from either scrib mutant 
(scrib1) or egr-scrib double mutant larvae (egr3; scrib1). We observed an 
upregulation of pvf1 in tumours from scrib mutant (scrib1) larvae when 
compared to wild type (w1118) wing imaginal discs (Fig 5.9A). This upregulation 
was reduced in tumours from egr-scrib double mutant larvae (egr3; scrib1). 
These results were encouraging and so we proceeded to test the functional role 
of pvf expression within the tumour.  
First we wanted to test if Pvf/Pvr signalling was required for the 
previously reported tumour associated increase in haemocytes. To address this 
we expressed GFP as a control or RNAi for the pvf Receptor Pvr specifically in 
the haemocytes of TBL (dlg40.2; hml>GFP and dlg40.2; hml>Pvr-IR respectively). 
We quantified the number of circulating haemocytes in control (dlg40.2; 
hml>GFP) and Pvr knockdown larvae (dlg40.2; hml>Pvr-IR). We found that Pvr 
knockdown larvae (dlg40.2; hml>Pvr-IR) had significantly fewer haemocytes than 
control larvae (dlg40.2; hml>GFP) (Fig 5.9B).  These data demonstrate the 
requirement of Pvr for increased numbers of haemocytes in TBL. 
We next wanted to examine if this had implications for tumour burden. To 
assess this we dissected tumours from control (dlg40.2; hml>GFP) and Pvr 
knockdown larvae (dlg40.2; hml>Pvr-IR) and stained for CC3 and measured tumour 
volume and % tumour cell death (Fig 5.9C-D’). We found that tumours from Pvr 
knockdown larvae (dlg40.2; hml>Pvr-IR) had a significantly larger tumour volume 
when compared to tumours from control larvae (dlg40.2; hml>GFP) (Fig 5.9E). 
Additionally, % tumour cell death in tumours from Pvr knockdown larvae (dlg40.2; 
hml>Pvr-IR) was significantly reduced (Fig 5.9F).  
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Taken together, these data indicate that tumour intrinsic Egr/TNF is 
required for a tumour related increase in haemocyte number via an upregulation 
of pvf1. 
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Figure 5.9 Pvr signalling is required for increased haemocyte numbers to 
restrict tumour burden. 
(A) qPCR analysis for pvf1 in wild type (w1118) wing imaginal discs and tumours 
from scrib (scrib1) mutant and egr-scrib (egr3; scrib1) double mutant larvae. (B) 
Quantification of haemocyte number in dlg40.2; hml larvae expressing either GFP 
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or Pvr-IR (t-test, ***p=0.0079) (C-D’) Immunofluorescence of tumours from 
dlg40.2; hml larvae expressing either GFP (C, C’) or Pvr-IR (D, D’) stained for 
actin and anti–cleaved caspase 3 (CC3) (outlined with dashed white line). Scale 
bars 100µm.  (E) Quantification of Tumour volume of tumours from dlg40.2; hml 
larvae expressing either GFP or Pvr-IR (t-test, **p=0.0026). (F) Quantification of 
% Tumour cell death in tumours from rom dlg40.2; hml larvae expressing either 
GFP or Pvr-IR (t-test, **p=0.0030). 
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5.4 Discussion 
Tumours are not isolated entities; they grow within tissues and have 
complex relationships with both the micro- and macro-environment (Gonda et 
al., 2009, Hanahan and Weinberg, 2011). Cancer treatment itself is rapidly 
evolving and clinical studies are now assessing the therapeutic potential of 
therapies that do not directly target tumour cells (e.g. using anti-angiogenic 
drugs). Cancer-related inflammation has been shown to act as both a tumour 
suppressor and tumours promoter (Karin and Greten, 2005, Mantovani et al., 
2008, Gonda et al., 2009, Balkwill and Mantovani, 2012).  
The results so far presented demonstrate a pivotal role of the Drosophila 
innate immune response in the control of tumour burden (Fig 5.10).  Moreover, 
we have made observations that suggest that haemocytes are able to recognize 
and eliminate transformed cells. 
 
5.4.1 The Fat body restricts tumour burden via Toll signalling 
Research in Drosophila has made seminal contributions to the understanding of 
innate immune signalling. The discovery of the role of Toll-like receptors (TLRs) 
in innate immunity was first made in the fruit fly and was rapidly followed by 
the characterization of their relationship with NFκB signalling (Lemaitre, 2004). 
These remarkable studies led to the identification of mammalian TLRs and to the 
delineation of their function in the control of numerous aspects of both the 
innate and adaptive immune responses (Akira, 2003, Beutler et al., 2003). 
Mammalian TLRs are important mediators of cancer-related inflammation 
(Karin and Greten, 2005, Maruyama et al., 2011). Nevertheless, the mechanisms 
that activate TLR signalling in cancers are still not well understood. It has been 
proposed that injured or necrotic cells release molecules not normally found in 
the extracellular milieu (e.g. DNA and nuclear proteins) that can act as 
endogenous ligands (Kim and Karin, 2011) 
During pathogen infection in Drosophila, the haemocytes produce the Toll 
ligand Spätzle to activate Toll signalling in the fat body (Shia et al., 2009).  We 
show that haemocyte derived Spätzle is also required to activate Toll signalling 
in the presence of a growing tumour (Fig 5.1, 5.2 and 5.3). Furthermore, 
inhibition of Toll signalling within the fat body resulted in increased tumour 
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burden through a suppression of tumour cell death (Fig 5.4). These data 
unequivocally demonstrate that activation of Toll signalling restricts tumour 
burden in Drosophila.  
 
5.4.2 The role of Haemocytes in the restriction of tumour burden. 
Tumour-associated macrophages (TAMs) perform a wide array of activities such 
as engulfing cellular debris from regions of tumour necrosis, remodelling blood 
vessels and further boosting the inflammatory response via cytokine production. 
This could result either in tumour suppression or promotion, depending on the 
context (Balkwill and Mantovani, 2001). 
It has been established that TBL have an increased number of haemocytes 
and that reducing the number of haemocytes in TBL results in an increased 
tumour burden (Pastor-Pareja et al., 2008). In addition, work from our 
laboratory has shown that tumour-associated haemocytes (TAHs) are recruited 
to imaginal disc tumours and express Egr/TNF (Cordero et al., 2010).  In this 
study, we have demonstrated the requirement of a haemocyte source of 
Egr/TNF for tumour cell death as depletion of Egr/TNF specifically in the 
haemocytes resulted in increased tumour burden and suppression of tumour cell 
death (Fig 5.5). Additionally, when we expressed a venus tagged form Egr/TNF 
we observed Egr/TNF particles in the tumour (Fig 5.6). 
 Our results demonstrate a requirement of Egr/TNF in haemocytes of TBL 
to restrict tumour growth through tumour cell death (Fig 5.10). 
 
5.4.3 Egr/TNF plays tissue specific roles in TBL 
Previous work from our laboratory demonstrated that systemic loss of Egr/TNF 
modifies the nature of scrib and dlg tumours and described a context-dependent 
role of Egr/TNF in tumours with and without oncogenic Ras (Cordero et al., 
2010). Our results presented here suggest that Egr/TNF plays tissue-specific 
roles that result in specific outcomes. Egr/TNF knockdown in haemocytes fully 
suppressed tumour cell death but did not affect Toll activation in the fat body 
(Fig 5.7). In contrast, tumour intrinsic Egr/TNF was required to activate JNK 
signalling within transformed epithelia and for the induction of Toll activation in 
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the fat body (5.8). Taken together our data suggest that Egr/TNF  is required 
in epithelial tumours for activation of the immune response and in haemocytes 
for tumour cell death downstream of Toll activation.  One question that I would 
like to address further is if Egr/TNF dependent cell death is also dependent on 
Toll activation in the fat body. To do this I would overexpress Egr/TNF and 
concomitantly inhibit Toll activation. This could be very interesting and if 
Egr/TNF dependent cell death is also dependent on Toll activation in the fat 
body this would explain why we do not observe Egr/TNF particles within normal 
epithelia.  
 
5.4.4 Egr/TNF dependent pvf1 expression is required for haemocyte 
proliferation 
Haemocyte number has been shown to modulate tumour burden (Pastor-Pareja 
et al., 2008). Pvf1 is the Drosophila homologue of the vertebrate VEGF/PDGF 
and activation of Pvr signalling has been shown to induce haemocyte 
proliferation (Zettervall et al., 2004). We have demonstrated that wing imaginal 
disc tumours produce pvf1 and that this is dependent on the presence of 
Egr/TNF (5.9). Functionally, we show that loss of Pvr signalling in haemocytes 
leads to a decrease in haemocyte numbers and tumour cell death, coupled with 
an increase in tumour volume. These results demonstrate that tumour associated 
increase in haemocyte number (Pastor-Pareja et al., 2008), is dependent on Pvr 
signalling within the haemocytes. We hypothesized that the tumour associated 
increase in haemocyte number may mediate Toll activation in the fat body 
through increased production of the Toll ligand Spätzle. In order to address this 
directly I would like to investigate the effect of modulation of haemocyte 
number on Toll activation in the fat body.  
 
5.4.5 Overall conclusions and impact 
In this study, we have used mutant larvae systemically deficient for polarity 
tumour suppressor genes. This experimental setup does not allow us to take into 
account the contribution of wild type untransformed cells. Many studies have 
shown that mosaic clones of scrib, lg(2)l and dlg mutant cells are eliminated by 
wild type cells through cell competition in an Egr/TNF, myc and hippo pathway 
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dependent fashion (Igaki et al., 2009, Froldi et al., 2010, Menendez et al., 
2010, Chen et al., 2012). Previous work from our laboratory has demonstrated a 
role for Egr/TNF in haemocytes for the elimination of lg(2)l mutant clones 
(Cordero et al., 2010). However, there have been reports that wild type cells 
can induce apoptosis of transformed cells but haemocytes are still required to 
remove apoptotic corpses of mutant cells (Lolo et al., 2012). While the normal 
epithelial neighbours could eliminate small clones of tumorous cells, the data 
presented here suggests the Drosophila innate immune system is indispensable 
for the elimination of already established tumours. In this context the 
haemocytes and fat body play essential roles in promoting tumour cell death.  
Our results also suggest that Egr/TNF plays epithelial intrinsic and extrinsic roles 
(Fig 5.10). 
 In order to further consolidate this work I would like to develop a new 
experimental system where I could examine the conclusions we have made here 
in the context of oncogenic cooperation between Ras and scrib (eyRasV12; scrib1) 
(Brumby and Richardson, 2003, Pagliarini and Xu, 2003, Cordero et al., 2010). I 
would do this by creating transgenic flies that form Ras-scrib tumours in the eye 
or wing imaginal discs and combine them with the Gal4/UAS system to address 
the role of Egr/TNF in the tumour, haemocytes and fat body. In previous work 
from our lab we demonstrated a context dependent role for Egr/TNF in Ras-scrib 
oncogenic cooperation (eyRasV12; scrib1), however these experiments were 
performed with systemic loss of Egr/TNF (Cordero et al., 2010). We have now 
demonstrated differential roles of Egr/TNF in the tumour and haemocytes and I 
would like to address how these roles are affected in larvae carrying Ras-scrib 
tumours (eyRasV12; scrib1). 
  As the fundamental mechanisms of innate immunity are evolutionary 
conserved from Drosophila to humans, this work could provide important insights 
into the relationship between tumours and the immune system in higher 
organisms.  
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Figure 5.10 Toll and EGR/TNF signalling restricts tumour burden in dlg 
mutant larvae. 
In dlg/scrib/lgl mutant larvae the imaginal discs have become neoplastic lesions 
that induce an immune response in the growing larvae. This is characterized by 
an increased number of haemocytes and activation of Spätzle dependent Toll 
signalling within the fat body. EGR/TNF signalling is required in the haemocytes 
for tumour cell death and in the tumour for the production of Pvf1 and Mmp1 
and activation of Toll signalling in the fat body. 
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6 General Discussion 
6.1 General Conclusions 
The role of inflammation and immunity in tumourigenesis and cancer progression 
is well established (Balkwill and Mantovani, 2001, Balkwill and Coussens, 2004, 
Balkwill et al., 2005, Balkwill, 2006, Mantovani et al., 2008, Balkwill, 2009, 
Balkwill and Joffroy, 2010, Balkwill and Mantovani, 2010, Balkwill and 
Mantovani, 2012). However, what factors regulate its context dependent effects 
are unknown. When are inflammation and an activated immune response good 
and when are they bad? How does a tumour use, what are essentially the host 
defense systems to its advantage? 
 In this thesis, I present data from three different projects that highlight 
the role of host immunity and inflammation in stress and tumourigenesis.   In 
this thesis I describe the effects and requirement of the innate immune 
pathways in Drosophila, the Toll, IMD and JAK/STAT pathways in three different 
genetic contexts. 
 I have presented and discussed data focused on uncovering novel adhesion 
independent roles of dp120ctn (see Chapter 3). I find that dp120ctn mutant flies 
are sensitive to heat shock, have a reduced lifespan. Transcriptional analysis of 
these mutants uncovered a unique transcriptional profile that included 
upregulation of several IMD/relish dependent DIRGs suggesting that dp120ctn 
might be required as a negative regulator of IMD signalling, a major arm of the 
Drosophila immune response.  Most interestingly, when I combined loss of 
dp120ctn with loss of the polarity tumour suppressor scrib I found that tumour 
burden was increased. This could suggest in this context that deregulated IMD 
signalling may contribute to increased tumour burden.  
In the Drosophila intestine, we have shown that Apc1 dependent 
hyperproliferation requires active JAK/STAT signalling as knocking down this 
pathway completely blocks hyperproliferation (see Chapter 4). We also observe 
an increased expression of the IL-6 like, upd3 upon Apc1 loss.  Moreover, the 
Drosophila intestine together with the trachea are two tissues that possess 
epithelial immunity and as such are able to mount local immune responses in 
order to maintain epithelial integrity (Lemaitre and Hoffmann, 2007). This is 
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very interesting when you consider that in the mammalian gut there is 
evidence that many inflammatory conditions such as Crohn’s disease predispose 
individuals to intestinal and colon cancer. In the Drosophila intestine an age-
associated dysplasia can be observed as a result of hyperproliferation that has 
been suggested to be dependent on an age associated increase bacterial load 
(Buchon et al., 2009a, Buchon et al., 2009b).  It would be interesting to address 
the contribution of systemic as well as local immunity to dysplasia and 
transformation in the Drosophila intestine. 
Finally, we demonstrated a non-autonomous tumour suppressive role of 
Toll and EGR/TNF signalling in Drosophila tumour bearing larvae. In previous 
work in our laboratory had been able to show that haemocytes were recruited 
from the circulation to the site of tumours and that they expressed EGR/TNF 
(Cordero et al., 2010). However, in this context due to the genetics we could 
not directly test the role of EGR/TNF in the haemocytes in this system. In order 
to do this we utilized whole mutants for the scribble group of polarity tumour 
suppressors in combination with tissue specific Gal4 drivers to overexpress and 
knockdown Toll and EGR/TNF signalling in the fat body and haemocytes 
respectively. We observed a significant increase in tumour burden when either 
Toll or EGR/TNF signalling was inhibited and a decrease in tumour burden when 
these signalling pathways were enhanced. These results describe tumour 
suppressive roles for both Toll and EGR/TNF signalling however we also show 
that EGR/TNF signalling is also required within the tumour for the activation of 
Toll signalling. Moreover, in our previous paper we have shown a context 
dependent role of systemic EGR/TNF. In the presence of oncogenic Ras we found 
that the presence of systemic EGR/TNF was in fact tumour promoting. These 
context dependent and likely tissue dependent roles of both EGR/TNF and Toll 
signalling will need to be investigated in order to understand how we can tip the 
balance in favor of tumour suppression and to uncover novel mediators of these 
context dependent effects. 
The immune system and inflammatory response can be both, a help and a 
hindrance to tumourigenesis and cancer progression. We know that in Drosophila 
immunity a controlled and measured response to any stimulus is key as a chronic 
activation of the immune response is detrimental to the host (see Chapter 3) 
(Brandt et al., 2004, Buchon et al., 2009a, Buchon et al., 2009b). Perhaps the 
tumour promoting affects that are observed are a result of the acute 
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immunogenicity of growing tumours which elicit a equally acute but 
prolonged activation of a host defense system which has evolved to find, 
eradicate the threat and return to equilibrium. If this is the case maybe we need 
to focus on how we first limit chronic inflammation that increases the risk of 
tumourigenesis as well as, how do we shut down a damaging response without 
causing any further harm to the host.  
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6.2 Limitations of Drosophila as a Cancer Model 
Drosophila melanogaster is a well characterized model organism that possesses a 
powerful genetic tool kit to address fundamental biological questions. 
Drosophila models of cancer are growing in number and the power of genetic 
screening is routinely being used to identify new modifiers of tumour biology. 
However, as with all models there are some limitations of Drosophila as a 
cancer model. Firstly, the lack of any vasculature in this system means that 
metastasis, as it is currently defined, could not occur by this mechanism in 
Drosophila i.e. the processes of intra and extravasation.  However, Drosophila 
possesses a tracheal network which carries oxygen around the fly could be a 
good model to study metastatic dissemination of tumour cells as it has been 
recently shown that secondary tumours can grow around tracheal branches and 
that these tumours have upregulated levels of branchless, a fly Fibroblast 
growth factor ortholog (FGF) which is normally expressed during branch 
formation (Hirabayashi et al., 2013).  
Another caveat that is often used to question the validity of Drosophila 
cancer research is how well Drosophila models of cancer can be associated to a 
specific cancer type. With respect to the Drosophila midgut, despite the 
relatively simple structure many signalling pathways that regulate the 
mammalian intestine regulate intestinal homeostasis in Drosophila. More over 
results presented in this thesis demonstrate the stark conservation of 
phenotypes associated with loss of the Apc tumour suppressor (Chap 4). In the 
case of the imaginal discs that are developing precursors of adult structures it is 
more difficult to ascribe a category. However, the imaginal discs are mitotically 
active epithelia which when transformed show remarkable histopathological 
similarities with human neoplasia and studies using the imaginal discs have 
provided insights many into tumour biology (Gateff, 1978, Woodhouse et al., 
1994, Woodhouse et al., 1998, Stefanatos and Vidal, 2011).  
 The ability to create genetically defined tumours in a tissue specific 
manner in Drosophila allows the interrogation of the systemic effects of tumour 
burden (Hariharan, 2012, Garelli et al., 2012, Colombani et al., 2012, 
Rudrapatna et al., 2013) (Chap 5).  
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In conclusion, despite the great differences between Drosophila and 
Humans I believe that cancer research using Drosophila has the potential to 
provide important insights into tumour biology and the tumour-host interaction. 
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